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CHAPTER I
INTRODUCTION

Biological rhythms are present throughout nature. Frequencies of
these rhythms can range from several cycles per second to only a single cycle
per year. Midway between these extremes are circadian (circa

= around, dia =

day) rhythms. These rhythms cycle over a 23 - 26 hour period and include the
rhythms of sleep, locomotor activity, hormone secretion and body
temperature. The time frame over which these rhythms repeats is genetically
determined. They are maintained in the absence of external cues.
Synchronization of these rhythms with the 24 hour light-dark cycle requires
the input of an outside "zeitgeber" or "time giver". In mammals, the most
powerful zeitgeber appears to be light. Information about changes in the
light-dark cycle is conveyed directly from photoreceptors in the retina to an
endogenous rhythm generator within the brain, the suprachiasmatic nucleus
(SCN). From the SCN, photic information is processed into neuronal and
hormonal signals that convey physiological information to the animal about
the time of day or season.
The pineal gland, via its secretion of the hormone melatonin, is an
important component of the neuroendocrine system regulating the
rhythmicity of an organism. The reception of light by the retina inhibits the
synthesis of melatonin, via a multisynaptic pathway that includes the SCN.
Synthesized from the amino acid tryptophan, melatonin has been suggested
to play a role in such diverse phenomena as the regulation of body
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temperature (Morton 1987), thyroid gland function (Vriend et al. 1977), and
pigmentation (Bagnara and Hadley 1970). One of the most extensively
studied functions of the pineal gland is its interaction with the hypothalamicpituitary-reproductive axis (Reiter 1980). More recently, several studies in
humans have suggested possible roles for melatonin in chronobiological and
psychobiological functions (Lowry et al. 1985; Vaughan 1984).
Neural regulation of melatonin synthesis has been well characterized.
At the onset of darkness, norepinephrine (NE) is released from nerve
terminals within the pineal gland and stimulates, via a.- and p-adrenergic
receptors on pinealocytes, the N-acetylation of serotonin (derived from the
amino acid tryptophan). The product of this reaction, N-acetylserotonin, is
methylated to form melatonin, which is then released into the general
circulation.
The idea that melatonin synthesis can be modulated by
neurotransmitters or circulating factors other than NE has recently gained
attention. One potential modulator, the amino acid glutamate, is an
important excitatory neurotransmitter within the central nervous system
(Mayer and Westbrook 1987). The recent report that glutamate is the
dominant excitatory neurotransmitter within the neuroendocrine
hypothalamus also suggests the possibility that this amino acid may play an
important role in other neuroendocrine systems (Van den Pol et al. 1990).
The present study is based on the observation that the pineal gland
possesses high levels of free glutamate and a number of "orphan" receptors
whose role in melatonin synthesis are unknown. The experiments in this
study were designed to test the hypothesis that glutamate plays a
neuromodulatory role in pineal gland function in the rat. Based on the fact
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that the NE content of the pineal gland exhibits a distinct circadian rhythm
(Craft et al. 1984), the first series of experiments examined amino acid content
of the pineal gland over the 24 hour light-dark cycle. The effect of
sympathetic denervation on amino acid content was also examined, as
several pineal gland rhythms, e.g. serotonin and melatonin content, are
known to be synchronized by the rhythmic release of NE from neurons of the
SCG. While glutamate has been previously demonstrated to inhibit the NEstimulated activation of the rate limiting enzyme in the synthesis of
melatonin in the rat in vitro (Govitrapong and Ebadi 1988), a source of
"transmitter" glutamate for the gland has not been demonstrated. To
determine if glutamate was concentrated in nerve terminals,
semiquantitative immunocytochemistry was employed.
The second series of experiments established the presence of
[3H]glutamate binding sites in the pineal gland of the rat. Not previously
demonstrated in the pineal gland of this species, [3H]glutamate binding site
number, affinity, and subtype were assessed with the use of in vitro receptor
autoradiography. The hypothesis that maintenance of glutamate binding site
number and affinity is dependent on an intact sympathetic innervation was
tested by examining [3H]glutamate binding after superior cervical
ganglionectomy (SCGx). [3H]Glutamate binding was also examined in pineal
glands obtained from animals sacrificed during the middle of the light and
dark periods.
A third series of experiments tested the hypothesis that glutamate
modulates pineal gland indole metabolism. The effect of glutamate and its
analogues on the adrenergic-stimulated secretion of melatonin in vitro was
examined.

CHAPTER II
REVIEW OF THE LITERATURE

The pineal organ is present in almost all vertebrate species. As
demonstrated by the fossil record, the pineal organ is an ancient structure,
believed to have been present in certain tetrapods of the Devonian and
Silurian periods (Oksche 1965). During evolution, there are few organs in the
body that have undergone as much change morphologically and functionally
as the pineal organ. The pineal organ of lower vertebrates, e.g. lamprey, fish,
and amphibians, consists of cone-like photoreceptors that synapse onto
second order neurons, whose axons project to various brain areas (Collin and
Oksche 1981). Pineal photoreceptors, like retinal photoreceptors, possess an
outer and inner segment, cell soma, and synaptic terminal. Pineal
photoreceptors possess many of the same cellular markers found in retinal
photoreceptors. Molecules found in both retinal and pineal photoreceptors
include opsin, a-transducin, S-antigen, and various photolabile pigments
(Collin et al. 1986; Oksche and Hartwig 1979). Cellular organelles specific to
the retinal photoreceptor such as the 9 X 2 + 0 cilium located in the outer
segment and synaptic ribbons located in the synaptic pedicle are also present
in pineal photoreceptors (McNulty 1984). In the retina, communication
between photoreceptors and secondary neurons is mediated by excitatory
amino acids released from the photoreceptor synaptic pedicle (Copenhagen
and Jahr 1989). These amino acids bind to glutamate receptors of the 24
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amino-4-phosphonobutyric acid (APB) subtype located on secondary neurons
(bipolar and horizontal cells) (Muller et al. 1988; Slaughter and Miller 1981).
The presence of autoreceptors for excitatory amino acid on photoreceptors is
also suggested by physiological studies that demonstrate the ability of
glutamate to depolarize photoreceptors (Sarantis et al. 1988; Tachibana and
Kaneko 1988).
In reptiles and birds, the typical photoreceptor becomes modified
(Collin and Oksche 1981). The most obvious changes are seen in the outer
segment where there is a decrease in the number of disks present and in the
synaptic pedicle where there is a disconnection from, and disappearance of,
second order neurons. While it is not clear whether all modified
photoreceptors can detect light directly, information about the light/ dark cycle
can be relayed to the photoreceptor indirectly via pathways originating in the
retina (Kappers 1965).
In mammals and snakes, the modified photoreceptor has been almost
completely replaced by the secretory pinealocyte (Collin et al. 1986). The
pineal organ in these species consists primarily of two cell types, glial cells and
chief cells (pinealocytes). Chief cells, while retaining many of the cellular
markers found in photoreceptors, e.g. opsin (Korf et al. 1985), S-antigen (Korf
et al. 1985), and a-transducin (Van Veen et al. 1986), are mainly involved in
indole metabolism (Reiter 1991). Cilia of the 9 X 2 + 0 variety (Karasek 1983)
and synaptic ribbons (McNulty et al. 1987) are also present in the secretory
pinealocyte. The pineal organ of mammals no longer possesses any direct
photoreceptive capacity but receives information about changes in the
light/ dark cycle via a multisynaptic pathway originating in the retina (Moore
1978).
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Peripheral Innervation of the Mammalian Pineal Gland
Information about changes in the light/dark cycle reaches the
mammalian pineal gland via a neural pathway originating in the retina
(Moore et al. 1964) (Fig. 1). Ganglion cells within the retina send
unmyelinated fibers to the suprachiasmatic nuclei (SCN) of the
hypothalamus via the optic nerve (Moore 1973). Most of the fibers in this
tract, referred to as the retinohypothalamic tract, cross before terminating in
the contralateral SCN (Moore and Lenn 1972). While it is known that
lesioning the SCN results in the loss of the cyclic production of the pineal
hormone melatonin (Moore and Klein 1974), the pathways that connect the
SCN to the pineal gland have not been fully defined. One possible route may
involve SCN projections to the paraventricular nucleus (PVN) of the
hypothalamus (Silverman et al. 1981). Lesions of the PVN have been shown
to disrupt the melatonin generating capacity of the pineal gland (Klein et al.
1983). While a direct projection from the PVN to the deep pineal (= pineal
tissue present within the dorsal posterior diencephalon) has been reported
(Reuss and Moller 1986), neurons in the PVN also have direct projections to
the preganglionic sympathetic neurons in the intermediolateral cell column
of the spinal cord (Swanson and Kuypers 1980). Axons from these
preganglionic neurons, which are located primarily in spinal cord levels Tl T3 (Gilbey et al. 1982), leave the spinal cord via the ventral roots and travel to
the superior cervical ganglion (SCG) where they synapse with postganglionic
sympathetic neurons (Rando et al. 1981). Projections from the SCG enter into
the brain by traveling with branches of the internal carotid artery (Hedger and
Webber 1976). Fibers destined for the pineal gland pass through the
tentorium cerebelli and reform as one or two nerves referred to as the nervi
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conarii (Kappers 1964). These nerves enter the pineal gland at its apex and
terminate in the pericapillary space (Kappers 1960) where they release the
neurotransmitter NE.

Fig. 1
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Central Innervation of the Pineal Gland in the Rat
While the sympathetic innervation of the rat pineal gland has been
extensively studied, knowledge of pinealopetal projections is limited. The
observation that all or most nerve terminals in the gland disappeared after
removal of the SCG led earlier investigators to believe that the gland was
innervated exclusively by the sympathetic nervous system (Kappers 1960).
More recent anatomical and electrophysiological studies, however, have
suggested that various brain regions project directly to the pineal gland via
the pineal stalk. Injection of the neuronal tracer horseradish peroxidase
(HRP) into the superficial portion of the pineal gland produced labeled fibers
and neurons within the habenular complex (Dafny 1983), while lesioning of
the medial habenular nuclei resulted in the appearance of degenerating fibers
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and terminals within the pineal gland (Ronnekleiv and Moller 1979). When
HRP was used as an anterograde tracer and injected into the PVN, labeled
fibers were found in the deep pineal and the pineal stalk (Reuss and Moller
1986). Injection of the more sensitive anterograde tracer Phaseolus

leucoagglutinin into the intergeniculate leaflett of the lateral geniculate
nucleus (Mikkelsen and Moller 1990) or the anterior and tuberal regions of
the hypothalamus (Fink-Jensen and Moller 1990) also produced labeled nerve
fibers that terminated in the deep pineal and pineal stalk.
Further evidence for the existence of central pineal connections has
been obtained from electrophysiological studies. In a study by Martin and
Meissl (1990), extracellular potentials evoked by brief photic stimulation of
the eyes were recorded from single cells in the pineal gland before and after
removal of the SCG. Removal of the sympathetic innervation did not
impede evoked extracellular potentials, suggesting that light information can
reach the pineal gland via central connections. Evoked potentials were also
recorded in the pineal gland after electrical stimulation of the habenula
(Ronnekleiv et al. 1980).
Although there appears to be considerable evidence in support of a
central innervation of the pineal gland, not all studies agree. Patrickson and
Smith (1987) noted, for example, that after careful injection of HRP into the
pineal gland labeled neurons could be found only within the SCG. It was
noted by these authors that "the encapsulation and lack of rigid attachment of
the pineal make it very difficult to penetrate" (Patrickson and Smith 1987).
They found that even when the pineal gland was surgically exposed and
carefully injected, tracer sometimes leaked from the site of entry. In cases
where tracer was found to leak, neurons in various brain areas were found to
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contain the HRP label (Patrickson and Smith 1987). A similar pattern of
labeling was observed by Stanley et al. (1987) after pineal glands were injected
with the neuronal tracers HRP, wheat germ agglutinin-HRP conjugate, fast
blue, and rhodamine microspheres. Additionally, the observation that some
sympathetic fibers from the SCG project into the medial habenular nuclei
after passing through the pineal gland (Patrickson and Smith 1987) suggests
that the degenerating nerve terminals found in the pineal gland after
lesioning the habenular nuclei (Ronnekleiv and Moller 1979) may not be
pinealopetal projections but simply retrogradely degenerating sympathetic
fibers. Likewise, the evoked potentials noted in the pineal gland after
stimulation of the habenula (Ronnekleiv et al. 1980) could be the result of
antidromic conduction along sympathetic fibers.

Biochemistry of Melatonin Synthesis
The pineal hormone melatonin is synthesized from the amino acid
tryptophan via a multienzymatic pathway. Tryptophan, found in low
concentrations within the pineal gland, is actively taken up from the
circulation and converted to 5-hydroxytryptophan by the mitochondrial
enzyme tryptophan hydroxylase (TPH) (Fig. 2) (Klein et al. 1981; Sugden 1979).
The activity of TPH is reported in rats to increase at night with peak activity
occuring 7 hours after lights out (Sitaram and Lees 1978). 5Hydroxytryptophan is subsequently oxidized to 5-hydroxytryptamine (SHT or
serotonin) by the cytoplasmic enzyme L-amino acid decarboxylase (L-AAD)
(Fig. 2). While the substrate specificity of this enzyme is low, the activity of LAAD is reported to be higher in the pineal than in any other tissue examined
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(Klein et al. 1981). Changes in L-AAD enzyme activity over the light-dark
cycle have not been reported.
Relative to other brain areas the pineal gland possesses high
concentrations of SHT (King et al. 1984; Quay 1963). The levels of this indole
vary over the light-dark cycle with concentrations being highest during the
light period and lowest at night (Quay 1963; Snyder et al. 1967). If the lightdark cycle is reversed and the animal is allowed to acclimate, the production
of SHT will likewise be reversed (Snyder et al. 1967). Because these rhythms
are endogenously generated, animals kept in constant darkness will have a
persistent SHT rhythm that will cycle approximately once every 24 hours.
Animals kept in constant light, on the other hand, display no rhythm in SHT
production, demonstrating the inhibitory nature of light on this rhythm
generator (Snyder et al. 1965).
In addition to its role as a melatonin precursor, SHT can be processed
via several different pathways within the pineal gland (Fig. 3). It can be
released unchanged into the general circulation or CSF (Aloyo and Walker
1988). It can be methylated to form 5-methoxytryptamine, a putative pineal
hormone (Pevet 1983). It can be converted by the mitochondrial enzyme
monoamine oxidase (MAO) into the unstable 5-hydroxyindole acetaldehyde,
which is subsequently converted to either 5-hydroxy indole acetic acid
(SHIAA) by the enzyme aldehydehydrogenase or to 5-hydroxytrptophol by the
enzyme alcohol dehydrogenase (Klein et al. 1981).
N-acetylation of SHT by serotonin N-acetyltransferase (SNAT), the rate
limiting enzyme in the synthesis of melatonin, produces N-acetylserotonin
(NAS) (Fig. 2). While there are two known types of N-acetyltransferase
enzymes within the pineal, the enzyme responsible for the production of
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NAS is highly specific for arylalkylamines (aromatic compounds that possess
a side chain with a primary ring) (Voisin et al. 1984). For this reason it is
often referred to as arylalkylamine N-acetyltransferase, or more commonly,
serotonin N-acetyltransferase (SNAT). A 24 hour rhythm in the activity of
SNAT has been demonstrated with a 20-100 fold increase in enzyme activity
during the night (Klein and Weller 1970). A full melatonin response can be
achieved with only a 10% activation of SNAT (Wheler et al. 1979). The
enzymatic conversion of SHT to NAS is the rate limiting step in the
production of melatonin.
The conversion of NAS to N-acetyl 5-methoxytryptamine (melatonin)
is catalyzed by the cytosolic enzyme hydroxyindole 0-methyltransferase
(HIOMT) (Fig. 2). Found in high concentrations in the pineal gland, HIOMT
makes up approximately 4% of the total soluble proteins (Jackson and
Lovenberg 1971). Although one early study reported no day-night variations
in HIOMT activity (Axelrod et al. 1965), this finding has not been
substantiated by other studies. Melatonin is released from the pineal gland at
night in a pulsatile fashion, with pulses occuring at the rate of 2 - 4 per hour
in the rat (Pang and Yip 1988).
Fig. 2
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Fig. 3
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Adrenergic Stimulation of Melatonin Production
Axelrod et al. (1969) first demonstrated the ability of NE to stimulate
melatonin synthesis in the rat pineal gland in vitro. It was soon shown that
the addition of the f3-adrenergic antagonist, propranolol, to NE-stimulated
glands prevented the expected increase in melatonin production. The
addition of the a-adrenergic antagonist, phenoxybenzamine, did not inhibit
melatonin production. It was assumed from these studies that NE exerted its
effects exclusively via the f3-adrenergic receptor (Wurtman et al. 1971). It was
later shown, however, that activation of the al-receptors by NE plays a role in
potentiating the f3-adrenergic induced response (Sugden et al. 1984).

il-Adrenergic Receptor Activation in the Rat Pineal Gland
f3-Adrenergic receptors have been characterized on rat pinealocyte
membranes using a variety of ligands including [3H]alprenolol (Kebabian et
al. 1975) and [3H]dihydroalprenolol (Cantor et al. 1981). More recent studies,
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which have used the ~-adrenergic ligand, [125I]iodocyanopindolol, have
identified a receptor with an apparent affinity (Kct) = 170 + 30 pM and a Bmax =
548 + 13 fmol/mg protein (Craft et al. 1985). The binding of NE to~adrenergic receptors initiates the interaction of the receptor with a
stimulatory guanine nucleotide protein (Gs) composed of three peptide
chains, a,~' y. The a subunit of the Gs molecule binds GTP and uncouples
from the G~ and Gy chains to activate adenylate cyclase, a membrane bound
enzyme responsible for the conversion of ATP to cyclic AMP (cAMP).
Activation of the ~-adrenergic receptor alone leads to approximately a 10 fold
increase in the cAMP content in the gland (Vanecek et al. 1985).
While peak levels of cAMP are reached within 10 minutes after
adrenergic stimulation and decline thereafter, levels remain elevated over
baseline throughout the dark period (Klein et al. 1978). Similarly, the activity
of phosphodiesterase, the enzyme responsible for degrading cAMP, is found
to be high throughout the dark phase (Minneman and Iverson 1976). In the
rat, SNAT activation with subsequent melatonin production occurs
approximately 1 - 2 hours after ~-adrenergic receptor stimulation (Klein et al.
1983; Simonneaux et al. 1989). This increase in SNAT activity can be blocked

by the administration of actinomycin D (an agent that binds DNA) as well as
cycloheximide (a peptidyltransferase inhibitor), suggesting that both
transcription and translation are necessary for the activation of this enzyme
(Romero et al. 1975). Activation of the pinealocyte ~-adrenergic receptor also
stimulates the production of cGMP 2 - 4 fold (Vanecek et al. 1985). The role of
cGMP in pineal gland indole metabolism is unknown (Sugden 1989).
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,a_-Adrenergic Receptor Activation in the Rat Pineal Gland
The ability of a-adrenergic agonists to mimic the NE-induced
stimulation of phospholipid metabolism was the first suggestion that aadrenergic receptors were present on the rat pineal gland. (Hauser et al. 1974).
The receptor was later defined pharmacologically using the ligand
[3H]dihydroergocryptine (Vacas et al. 1980) and shown to activate
phosphatidylinositol metabolism via a postsynaptic mechanism (Smith et al.
1979). al-Adrenergic receptors have been subsequently characterized with the
use of the specific ligand [1 2SI]-2-[~-(4-hydroxyphenyl)-ethylaminomethyl]tetralone ([125I]HEAT) and found to possess a Kd = 48 + pM and Bmax = 341.6
+ 126.4 fmol/mg protein (Sugden and Klein 1985). An approximate 1:2 ratio

of a to

~

receptors has been reported in the rat pineal gland (Dickinson et al.

1986).
Noradrenergic stimulation of the pineal gland leads to the activation of
the membrane bound enzyme phospholipase C (Ho et al. 1988). Based on the
observation that the NE-stimulated production of inositol monophosphates
is inhibited by the addition of al-adrenergic antagonists in vitro, it is
postulated that the activity of this enzyme is controlled by the al-adrenergic
receptor. In many cell types, phospholipase C cleaves inositol-containing
membrane phospholipids to produce the second messengers inositol 1,4,5
triphosphate (IP3) and diacylglycerol (DAG). IP3 production causes the release
of Ca2+ from internal cellular stores while DAG stimulates the translocation
of protein kinase C (PKC) from the cytosol to the cell membrane where it is
activated. In the pineal gland little, if any, IP3 is formed in response to NE
stimulation (Sugden et al. 1988; Sugden et al. 1987). Conversely, the activity
of PKC in pinealocytes is high (Sugden 1991). While DAG is known to
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activate PKC in many cell types, there is some question as to whether DAG
activates PKC in the pinealocyte. It has been shown, for example, that .
maximal PKC activity can be detected in pinealocytes three minutes after
stimulation without any prior or concurrent increase in DAG. The isoforms
of PKC present in the pineal gland are of the ex (80%) and

p (20%) variety

(Yoshida et al. 1988).
In addition to the stimulation of phospholipase C, activation of the cxladrenergic receptor leads to an influx of Ca2+ into the pinealocyte (Sugden et
al. 1987). Intracellular levels of Ca 2+ increase from a basal level of 100nM to
approximately 350 nM in one minute and remain high for about 30 minutes
after stimulation (Sugden, et al. 1987). The inability of nifedipine (a Ca2+
channel blocker) to inhibit this increase suggests that Ca2+ is not entering the
cells via the well know voltage-sensitive Ca2+ channel present on
pinealocytes (Sakai and Marks 1972). While an increase in intracellular Ca2+
appears to be necessary (and perhaps solely responsible) for the translocation
and activation of PKC (Ho et al. 1988), the addition of Ca2+ ionophores by
themselves are not sufficient to activate phospholipase C.
PKC has been reported to have a negative feedback effect on the
activation of the cxl-adrenergic receptor. A one minute pretreatment of
pinealocytes with phorbol myristate acetate (PMA) (an activator of PKC)
before the administration of NE reduced the cxl-adrenergic induced increase
in intracellular Ca2+ by 50 % (Sugden et al. 1988). Likewise, pretreatment with
PMA inhibited the ability of NE to stimulate the production of inositol
monophosphate (Sugden et al. 1988). These authors have suggested that
activation of the cxl-adrenergic receptor leads to an incease in intracellular
Ca 2+ which causes the translocation of PKC which inhibits the further
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increase in intracellular Ca 2+. It is believed that PKC phosphorylates and
desensitizes tha al-adrenergic receptor to further stimulation (Leep-Lundberg
et al. 1986).
Additionally, a role for arachidonic acid metabolites in pineal gland
function has been suggested by the observation that lipoxygenase inhibitors
decrease NE-stimulated melatonin production while the products of this
enzyme, 12- and 15-hydroxyperoxy-6,8,11,14-eicosatetraenoic acid (HPETE),
increase melatonin production (See Fig. 4) (Sakai et al. 1988). Based on the

Fig. 4
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observation that activation of the pinealocyte al-adrenergic receptor, as well
as administration of Ca2+ ionophores and phorbol esters to pinealocytes
stimulates the release of arachidonic add, it has been suggested that the aladrenergic receptor mediates arachidonic acid metabolism. It has also been
shown that activation of the al-adrenergic receptor or direct activation of
PKC by phorbol esters causes an increase in intracellular pH (Ho et al. 1989).
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,a-Adrenergic Potentiation of 13-Adrenergic Stimulated
cAMP and cGMP Production
Stimulation of the cx1-adrenergic receptor by itself does not increase
cyclic nucleotide production (Vanecek et al. 1985). Activation of this receptor
does, however, potentiate the ~-adrenergic induced production of cAMP and
cGMP in pinealocytes 60 to 100 fold (Sugden 1990; Vanecek et al. 1985). Based
on the observation that synthetic activators of PKC, e.g. phorbol 12-myristate,
13-acetate (PMA) and oleoyl acetyl glycerol (OAG), mimic the ability of cx1adrenergic agonists to potentiate the ~-adrenergic induced response, PKC has
been suggested to mediate this process in vivo. Likewise, if intracellular
calcium is increased in pinealocytes by the use of Ca2 + ionophores or
depolarizing concentrations of K+ (treatments known to activate PKC), ~adrenergic induced cAMP and cGMP production is enhanced. The fact that
cx1-adrenergic receptor activation can potentiate cAMP and cGMP production
stimulated by either cholera toxin or forskolin suggests that PKC exerts its
effects either via the Gs protein and/ or adenylate cyclase and probably not via
the ~-adrenoceptor. Activation of the cx1-adrenergic receptor does not appear
to potentiate the ~-adrenergic induced increase in cAMP and cGMP by
inhibiting the enzyme phosphodiesterase because cx-adrenergic potentiation
of the ~-adrenergic induced response is still noted when high concentrations
of phosphodiesterase inhibitors, e.g. IBMX, are added to pinealocyte cultures
(Sugden and Klein 1988).
The cx1-adrenergic potentiation of ~-adrenergic induced cGMP
production appears to differ somewhat from that of cAMP. While an increase
in intracellular calcium potentiates ~-adrenergic induced cGMP formation,
activation of PKC alone had no effect (Sugden et al. 1985). Activators of PKC
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can, however, potentiate the ~-adrenergic induced cGMP production in a dose
dependent manner if intracellular Ca2 + is simultaneously increased. The
exact role of Ca 2+ in cGMP potentiation is not clear.

Differential Regulation of cAMP by PKC Isozymes
There are several isoforms of the enzyme PKC. The a., ~I, ~II, and y
forms are usually present in large quantities within cells while the

o, E, and~

forms are found in smaller amounts (Nishizuka 1988). Functional
differences between these isozymes have only recently been discovered when
it was determined that two of the PKC subspecies differentially affect cAMP
production (Gusovsky and Gutkind 1991). In cells that only possess the

a,

PKC

isozyme, e.g. NIH 3T3 cells, activation of PKC leads to an inhibition in
forskolin-stimulated cAMP production. Activation of PKC in cells that
possess both the a. and y isozymes, e.g. PC12 cells, results in a potentiation of
cAMP generation (Gusovsky and Gutkind 1991). While only the

a,

and~

isoforms of PKC have been identified in the pineal gland (Yoshida et al. 1988),
the exact isozyme involved in potentiating the ~-adrenergic induced cAMP
and cGMP response has not been determined. In addition to the ability of
PKC to potentiate cAMP generating systems, it remains a possibility that
cAMP levels may be inhibited by receptors that activate the a. PKC isozyme.
In the pineal gland, 80% of the PKC present is of the a. variety (Yoshida et al.
1988).
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Functional Implications of the a-Adrenergic Potentiation
of the !l-Adrenergic Induced Response
The exaggerated cAMP response initially caused by activation of both aand 13- adrenergic receptors by NE, or by PE-potentiation of cholera toxin
stimulated cAMP production is of limited duration (Sugden et al. 1988;
Sugden and Klein 1988). In both systems, cAMP levels declined to nonpotentiated (equivelent to 13-adrenergic induction alone) levels by 60 minutes.
Activation of the al-adrenergic receptor quickly leads to its desensitization
(Sugden et al. 1988). The physiological role of this large initial increase in
cAMP may determine the extent of SNAT activity while the lower steady
state levels of cAMP that follow function to maintain SNAT activity. It is
known, for example, that the addition of 13-adrenergic antagonists to
pinealocytes in vitro several hours after SNAT induction leads to a rapid
decline in SNAT activity (Deguchi and Axelrod 1972).
The potentiation in cAMP and cGMP levels seen after both a- and

13-

adrenergic receptor activation are paralleled by a two fold potentiation in
SNAT activity (Klein et al. 1983). Whether an amplification in melatonin
production also occurs remains controversial. In hamster pineal glands
cultured in vitro, addition of PE potentiated the isoproterenol (Iso) -induced
increase in melatonin production in the gland, while no potentiation in the
amount of melatonin secretion into the media was noted (Santana et al.
1989). In an in vivo experiment in which hamsters were injected with
prazosin, an a-adrenergic antagonist, during the middle of the dark phase, an
inhibition of pineal and serum melatonin was noted one hour after injection,
while later time points (2 and 3 hours post-injection) were not affected
(Stankov et al. 1990). In ovine pinealocytes cultured in vitro, PE potentiated
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the !so-induced production of melatonin within cells without any
Potentiation in the cAMP response (Howell and Morgan 1991).
It appears that little PKC is necessary in pinealocytes to potentiate the 13-

adrenergic response. After downregulating PKC by 91 - 97%, 13-adrenergic
induced cAMP was inhibited only 45-55%, while SNAT activity was not
inhibited at all (Sugden 1991). This suggests that not all of the cAMP
produced by the activation of both a- and 13-adrenergic receptors is necessary
for the full induction of SNAT. The author of this study (Sugden 1991)
concluded by stating "... the physiological role of the al-adrenergic
potentiation mechanism in regulating SNAT induction, and hence
melatonin synthesis, in vivo is uncertain".

Other Receptor /Binding Sites Present in the Rat Pineal Gland
In addition to the well characterized adrenergic receptors, the pineal
gland possesses many other receptor types whose role in indole metabolism is
not known (Table 1). Many of these compounds appear to play a
neuromodulatory role, i.e. they have no effect on their own but modulate
adrenergic-induced SNAT activity and subsequent melatonin production.
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Table 1. - Receptor /Binding Sites in the Pineal Gland
Monoamines
Receptor/
binding site
[*]ligand
~-adrenergic

Affinity
(Kct)

nM
0.17

[125I]iodoQ'.ano12indolol

a1-adrenergic

0.05

[125J]HEAT

<X2Dadrenergic

1.40

[3H]rauwolscine

D1Dopaminergic

0.56

[3H]SCH 23390

D2Dopaminergic

0.18

[3H]s12iro12eridol

2.10

5HT2

1.26

&

[3H]SJ2i~rone

Receptor
numl:er

(Bmax)
548 fmol
/mg
protein

Effect
of
SCGx
increase
Bmax

342 fmol
/mg
protein

increase
Bmax

71 fmol
/mg
protein
974 fmol
/mg
protein
37 & 630
fmol/
mg
protein
193
fmol/mg
protein

Not
determined

Function

Ref.

Stirn. cAMP &
cGMP; increase
SNAT activity &
melatonin prod.

1

Stirn. PI
hydrolysis &
Ca2+ influx·
increase PKC
activity
Inhibits SNAT
activity

2

I

3

Not
determined

Unknown

4

Not
determined

attenuates NEstimulated
SNAT activity

5

Not
determined

Unknown

6

1)

Craft et al. 1985 (rat)

2)

Sugden and Klein 1984 (rat)

3)

Simmonneaux et al. 1991 (bovine); Alphs et al. 1984 (rat/function)

4)

Simmonneaux et al. 1990 (bovine)

5)

Govitrapong et al. 1984 (bovine); Govitrapong et al. 1989 (rat/function)

6)

Govitrapong et al. 1991 (bovine)
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Table 1 - Continued

Amino acids
Receptor/
binding site
[*]ligand
Glutamate

Affinity
(Kd)
nM
534

[3H]Glutamate

GABA
[3H]GABA

16.5
&

567

Receptor
numrer

(Bmax)

Effect
of
SCGx
Not
determined

4840
fmol
/mg
protein
121 &
Not
2470
determined
fmol/mg
protein

Function

Ref.

Inhibits NEstim. SNAT
activity

7

Inhibits
melatonin
prod.

8

Enhances lsostim. mel.
production
Unknown

9

Benzodiazepines
Peripheral-type
Benzodiazepine
[3H]Ro 5-4864

2.46

Peripheral-type
Benzodiazepine
[3H]PK 11195

4.40

Central-type
Benzodiazepine
[3H]flunitrazenam

2.80

24000
fmol/mg
protein
2040
fmol/mg
protein
124
fmol/mg
protein

Decrease
Bmax
Not
determined
Not
determined

Enhances Isostim. mel.
production

10

11

7)

Govitrapong et al. 1986 (bovine); Govitrapong et al. 1988 (rat/function)

8)

Ebadi and Chan 1980 (bovine); Rosenstein et al. 1989 (rat/function)

9)

Weissman et al. 1984 (rat); Winters et al. 1991 (rat/function)

10)

Suranyi-Cadotte et al. 1987 (human)

11)

Suranyi-Cadotte et al. 1987 (human); Winters et al. 1991 (rat/function)
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Table 1 - Continued

Peptides
Receptor/
binding site
[*]ligand
VIP
[125I]VIP

Affinity
(Kd)
nM

Not
determined 1
Not
Argininevasopressin 4-9 determined 1
[35s]VP 4-9
1.00
Neuropeptide
y
[125I]NPY

Receptor
number

(Bmax)
Not
determined 1
Not
determined 1
40
fmol/mg
protein

Effect
of
SCGx
Not
determined
Not
determined
Not
determined

Function

Stirn. SNAT
act. /melatonin
production
Enhances NEstim SNAT
activity
See note2

Ref.

12

13

14

lNote: Autoradiographic visualization of [125J]VIP and [35S]VP4-9 binding in
whole brain demonstrated the presence of a high concentration of VIP and
VP4-9 binding sites in the pineal gland relative to other brain areas. KcI and
Bmax values were determined for whole sections and did not differentiate
between brain and pineal gland.
2Note: The role of NPY in pineal gland function is controversial. Olcese
(1991) reported that NPY is a potent inhibitor of NE-stimulated melatonin
secretion in vitro (ICso 0.4 nM) while Vacas et al. (1987) reported that NPY
(l0nM) enhances NE-stimulated melatonin production in vitro.
12)

Besson et al. 1986 (rat); Kaneko et al. 1980 (rat/function); Simonneaux
et al. 1990 (rat/function)

13)

De Kloet et al. 1985 (rat); Stehle et al. 1991 (rat)

14)

Olcese 1991 (rat); Vacas et al. 1987 (rat/function)
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Table 1- Continued

Other
Affinity
Receptor/
(Kci)
binding site
[*]ligand
nM
0.42
Estrogen
nuclear
complex
[3H]estradiol
Sigma opiate Not
[3H] 1,3-di-ortho- detertotiI-gyanidine mined 1
M uscarinic0.01
Cholinergic
[3HlONB
A2-Adenosine
51
[3H]NECA

Receptor
number

(Bmax)
1.6 fmol
/mg
tissue
Not
determined 1
32 fmol
/mg
protein
1060
fmol/mg
protein

Effect
of
SCGx
Decrease
Bmax

Function

Ref.

Unknown

15

Not
determined

Unknown

16

No change

Stirn. PI
hydrolysis

17

Not
determined

Enhances NEstimulated mel.
prod.

18

1NOTE: Autoradiographic visualization of [3H]DTG binding in whole brain
demonstrated the presence of a high concentration of cr binding sites in the
pineal gland relative to other brain areas. Kd and Bmax were not determined.

15)

Cardinali 1977 (rat)

16)

Jansen et al. 1990 (rat)

17)

Taylor et al. 1980 (ovine and rat); Laitinen et al. 1989 (rat-function)

18)

Sarda et al. 1989 (rat); Vasas et al. 1989 (rat-function)
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Melatonin - Its Role In Vivo
Over the course of a year, animals in their natural habitat are subjected
to changes in day length. In seasonally reproductive animals, e.g sheep and
hamster, the length of the photoperiod that an animal is exposed to per day
determines reproductive success. This is most clearly seen in the hamster
where a minimum of 12.5 hours of light is required to maintain normal
testicular size (Elliott 1976). If the animal is exposed to anything less than 12.5
hours of light, the testes will begin to regress and spermatogenesis is inhibited
(Elliott 1976). This inhibitory effect of shortened photoperiod can be reversed
by removal of the pineal gland (Reiter 1972). The fact that testicular atrophy
can be induced in pinealectomized hamsters by a daily regimen of melatonin
administration (3 injections of 25 ug at three hour intervals), suggests that
melatonin is responsible for this inhibition in vivo (Tamarkin et al. 1977). It
should be noted, however, that melatonin's role in reproductive function is
not always inhibitory. In sheep, exposure to short days stimulates
reproductive activity (Wayne et al. 1990). Mating in this species occurs in the
fall resulting in lambs that are born in the spring. Administration of
melatonin to female sheep in the summer has been reported to advance the
onset of cyclical ovarian activity (Nowak et al. 1990).
The site of action of melatonin within the central nervous system is
not known. Receptors for melatonin have only recently been characterized
and appear to be present in the pars tuberalis and SCN regions of the brain
(Reppert et al. 1988; Williams and Morgan 1988). It has been postulated that
melatonin acts via the SCN to alter the release of gonadotropin releasing
hormone (GnRH) and thereby alters reproductive function.
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The human pineal gland, like the pineal gland of all other animals, has
elevated levels of melatonin secretion at night (Lynch et al. 1978). The
function of this hormone in humans is not clear however. Administration
of exogenous melatonin (lmg/kg) to human subjects during the day has been
reported to induce subjective sleepiness (Lieberman et al. 1984). A role for
melatonin in seasonal affective disorder (SAD), a form of clinical depression
noted during the winter months when daylength is shorter, has been
postulated (Thompson et al. 1990). Symptoms of this disorder include a
greater need for sleep, weight gain, and a craving for carbohydrates. Therapy
for this disorder includes exposing the patient to high intensity light (Oren et
al. 1991). Melatonin levels abruptly drop in humans subjected to bright light
during the night when melatonin levels are normally high (Thompson et al.
1990).

Excitatory Amino Acids / Pharmacology
Within the human brain, there are an estimated 1012 - 1014 neuronal
synapses responsible for the transduction of chemical information between
cells (Purves and Lichtman 1985). Inhibition at these synapses are mediated
by a number of well established neurotransmitters including dopamine,
GABA, norepinephrine, and serotonin. By contrast, most excitatory synaptic
transmission appears to be mediated by a single compound or family of
compounds chemically related to the amino acid L-glutamate. The excitatory
properties of glutamate were first demonstrated in 1954 when it was reported
that the injection of L-glutamate or L-aspartate directly into the brain or
carotid artery of laboratory animals resulted in seizures (Hayashi 1954). The
earlier observation that tissue glutamate levels were highest in the brain had
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already suggested an important role for glutamate in neuronal function
(Waelsch 1951). A known intermediate in the tricarboxylic acid cycle,
glutamate was believed to be linked to the high metabolic demands of the
tissue. Later studies, noting the chemical similarities between this amino acid
and the known neuroinhibitor GABA, suggested that glutamate had, in
addition to its metabolic role, a neuroactive role. Early reports describing an
inhibitory role for glutamate noted its ability to initiate spreading depression
within the brain (Purpura et al. 1959; Van Harreveld 1959). However, these
studies were not substantiated and evidence accumulated for glutamate's role
as an excitatory agent. It had been demonstrated, for example, with the use of
intracellular recording techniques that both L-glutarnate and L-aspartate
exerted a depolarizing effect on spinal cord neurons (Curtis et al. 1959).
Unlike other known neurotransmitters, however, glutamate was found to
stimulate neurons in nearly all areas of the central nervous system tested,
including brain stern neurons (Curtis and Koizumi 1961), cerebral cortical
neurons (Phillis and Krnjevie 1961) and thalarnic neurons (Curtis and Davis
1962). To earlier investigators, this non-specific nature of L-glutarnate and the
fact that high concentrations (1Q-3 to 10-4 M) were needed to evoke a response
made its role as a neurotransmitter seem unlikely. In addition, no specific
enzymatic system capable of terminating glutamate's stimulatory action
appeared to be present, suggesting that if a separate excitatory system did exist
it was not glutamate, but a related compound that acted as the endogenous
transmitter. Extensive structure-activity studies were undertaken in an
attempt to determine the functional groups responsible for glutamate's
stimulatory effect. These studies resulted in the discovery of several new
"excitants" including N-rnethyl-D-aspartate (NMDA), L-cysteic acid, D-
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homocysteic acid, and D,L-aminoadipic (Watkins 1962). For many years the
nature of glutamate's excitatory action within the CNS remained undefined.
In addition to the obvious differences between glutamate and other known
neurotransmitters, inhibition of glutamate's stimulatory effect had not been
demonstrated with the use of specific receptor antagonists. Early reports of
regional differences (spinal cord and cerebral cortex) in the rank order
potencies of various glutamate analogues were the first suggestion of a more
specific nature of action for this amino acid (Curtis and Watkins 1960;

Krnjevic and Phillis 1963), but the data were not conclusive. One of the
first definitive reports of the specific nature of glutamate's stimulatory action
came several years later when it was demonstrated in the cat spinal cord that
ventral horn neurons were significantly more responsive to L-aspartate than
L-glutamate, while dorsal horn neurons preferentially responded to Lglutamate (Duggan 1974). In another study that same year, NMDA and kainic
acid were proposed to act at different receptor sites; NMDA appearing to act at
an "aspartate preferring" site and kainic acid acting at a "glutamate
preferring" site (McCulloch et al. 1974). Relatively selective antagonism of Lglutamate and L-aspartate responses had already been obtained with the
compounds L-glutamic acid diethyl ester (GDEE) and 3-amino-1hydrxpyrrolidone (HAP), respectively (Haldemann and McLennan 1972)
further supporting the idea of receptor subtypes. In addition, membrane
binding studies utilizing glutamate demonstrated for the first time that
glutamate binding was saturable, of reasonably high affinity, and inhibited by
other neuroexcitatory amino acids (Michaelis et al. 1974; Roberts 1974)
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NMDA Receptor
It was becoming increasingly evident that glutamate's actions in _brain

were mediated by at least two distinct receptor subtypes. The first
unequivocal report of receptor differentiation was the demonstration by
Evans et al. that NMDA responses could be selectively inhibited by the
divalent cation Mg2+. Responses to quisqualate and kainate were unaffected
by concentrations of Mg2+ as high as 20mM (Evans et al. 1977). It was also
noted at this time that D-alpha-aminoadipate (DAA), a compound previously
shown to have weak excitatory action in its racemic form, selectively
inhibited responses to NMDA (Biscoe et al. 1977). It was later discovered that
substitution of the carboxy group of DAA with a phosphonate group
produced an antagonist, D(-)-2-amino-5-phosphonopentanoate (APS), that
was much more selective and potent than DAA (Davies et al. 1981). This
antagonist and several other related antagonists were soon superceeded in
potency by heterocyclic derivatives of APS which included the compound 3-

(( +)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), an antagonist
approximately 5 times more potent than APS (Harris et al. 1986) More
recently another heterocyclic derivative of APS, CGS-19755 was found to be an
even more potent antagonist at the NMDA site (Lehmann et al. 1988).

NMDA Receptor - Ionophore Complex
In addition to the transmitter recognition site which binds compounds
such as NMDA, DAA, APS, CPP, and CGS-19755, several other sites are
present within the receptor -ionophore complex. These include (a) a Mg2 +
binding site (Mayer et al. 1984; Nowak et al. 1984); (b) an allosteric regulatory
site that binds glycine (Johnson and Ascher 1987; Kleckner and Dingledine
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1988); (c) a phencyclidine binding site (Anis et al. 1983; Coan and Collingridge
1987; Wong et al. 1986); (d) a Zn2 + binding site (Peters et al. 1987; Westbrook
and Mayer 1987); and (e) a polyamine binding site (Ransom and Stec 1988).

Non-NMDA Receptors: AMP A and Kainate
Often referred to as the non-NMDA receptors, a-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors have not
been clearly distinguished from one another on the basis of selective
antagonist binding. It was the observation of differences in rank order
potencies when receptors were labeled with either [3H] kainate (domoate>
kainate> quisqualate>> L-glutamate) (Monaghan and Cotman 1982) or [3H]
AMPA (quisqualate> AMPA L-glutamate> kainate) (Honore et al. 1982) that
first supported the idea of separate receptors. The most convincing evidence
for separate kainate and AMPA receptors came from studies in which the
anatomical localization of [3H] kainate and [3H] AMP A binding within the
brain was examined. It was demonstrated that kainate binding is
concentrated in the hippocampal CA3 stratum lucidum, deep cerebral cortical
layers, striatum and granule cell layer of the cerebellum (Monaghan and
Cotman 1982; Unnerstall and Wamsley 1983) whereas [3H] AMPA binding
sites are more numerous in the CAl stratum radiatum, outer cortical layers,
lateral septum, and molecular layer of the cerebellum (Monaghan et al. 1984;
Olsen et al. 1987). The recent development of the antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) has provided specific inhibition of a
kainate/ quisqualate response but could not distinguish between the two
receptor subtypes (Honore et al. 1988). Another recently developed
antagonist, 2-amino-3-[3-(carboxymethoxy)-5-methylisoxazol-4-yl]propionic
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acid (AMOA), has been reported to selectively inhibit kainate responses
without significantly decreasing AMPA-induced responses (Frandsen et al.
1990).

APB Receptors
In the early 1980's the antagonistic properties of APB had been reported
at several glutamate using synapses (Collins 1982; Davies and Watkins 1982;
Lanthorn et al. 1984). APB did not, however, appear to antagonize the effects
of NMDA, quisqualate, kainate, and L-glutamate if applied simultaneously,
suggesting that APB was acting at a fourth receptor subtype (Evans et al. 1982).
Recent evidence suggests a presynaptic site of action for APB (Forsythe and
Clements 1988).

Glutamate Metabotropic/ Trans-ACPD Receptor
Glutamate has been shown to stimulate the production of inositol
phosphate in various neuronal preparations (Nicoletti et al. 1986; Sladeczek et
al. 1985). When the pharmacological properties of the receptor mediating this
effect were examined, it was noted that L-glutamate, quisqualate, ibotenate,
and 1-amino-cyclopentyl-1,3-dicarboxylate (ACPD) stimulated inositol
phosphate production while NMDA, AMP A and kainate did not (Monaghan
et al. 1989; Nicoletti et al. 1986). This stimulation of inositol phosphate
production could not, however, be blocked by known quisqualate/kainate or
NMDA antgonists, indicating that this receptor differed from the known
glutamate receptors (Schoepp and Johnson 1988). ACPD, the most selective
agonist at this receptor, appears to be linked to a pertussis toxin-sensitive G
protein that mediates the production of inositol phosphates. This receptor
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appears to be important during normal neuronal development and synaptic
stabilization as demonstrated by the fact that receptor efficacy decreased after
synaptogenesis and reappeared following deafferentation (Schoepp et al.
1990).
Molecular Biology of Glutamate Receptors - Are There
More than Five Receptor Subtypes?
Glutamate-evoked responses at neuronal synapses are mediated by the
opening of ion channels (ionotropic receptors) and/or the stimulation of
second messenger systems (metabotropic/ ACPD receptors). Glutamate
receptor subtypes linked to ion channels include the AMPA, kainate, NMDA
and APB receptors. The AMP A and kainate receptors have been
demonstrated to gate ion channels that permit the influx of monovalent
cations such as Na+ and K+, while the NMDA receptor complex is believed to
modulate a voltage-sensitive Ca2+ channel (Watkins et al. 1990). The recent
cloning of the genes for several of the glutamate receptor subtypes suggests a
more complicated arrangement. It is now known that there are at least 4
subtypes of AMPA receptor, refered to as GluR-A GluR-B, GluR-C, GluR-D
(or GluR-1, -2, -3, -4) (Hollmann et al. 1989; Keinanen et al. 1990). In addition,
the cDNA nucleotide sequence of each receptor subtype possesses 115 base
pairs that are found to exist in 1 of 2 sequence versions. These two versions
are refered to as "flip" and "flop" (Sommer et al. 1990). This increases the
number of molecular species to 8. Each receptor subtype demonstrates a
unique mRNA expression pattern in the brain (Keinanen et al. 1990).
While these receptors display typical AMP A pharmacology (Keinanen
et al. 1990), the expression of two of the subtypes, GluR-A or GluR-C, produces
ion channels that are highly permeable to Ca2+ (not an AMPA-like
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characteristic) (Hollmann et al. 1991). If GluR-B is expressed along with GluRA or GluR-C an ion channel that is impermeable to Ca 2+ is formed
(Hollmann, et al. 1991). This led Richard Miller to state that ".. .if the potential
number of kainate / AMPA receptors available from combinations of
multiple gene products and splice varients are considered, the resulting
diversity is truly mind boggling ... although it could be said that all these
receptors will be activated by excitatory amino acids, wide variations in their
pharmacology and biophysical properties should be expected" (Miller 1991).
While each receptor subtypes forms a functional ion channel when
expressed alone, the composition of native receptors is not known. Three
subtypes of kainate receptor have also been cloned, GluR-E (GluR-5) (Bettler
et al. 1990), GluR-F (GluR-6) (Egebjerg et al. 1991) and KA1 (Werner et al.
1991), Like the AMPA receptor, each receptor subtype possesses a unique
anatomical distribution. KA1, while binding [3H]kainate, does not appear to
be functional in electrophysiological studies. The metabotropic receptor has
also been cloned (Masu et al. 1991), and may exist in multiple forms (Henley
and Johnston 1991). The glutamate binding site of the NMDA receptor
complex has been the most recent glutamate receptor cloned (Kumar et al.
1991).

Glutamate Uptake Sites
After it is released from nerve terminals glutamate is removed from
the extracellular space by uptake into neurons and glia. Distinguished by
their ion dependencies, two distinct systems for the uptake of glutamate exist.
The first site to be described, a Na+-dependent uptake site, displayed high
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affinity for the glutamate analogues D-aspartate, L-aspartate, threo-~hydroxyaspartate (TBH), and L-cysteine sulfinic acid . Early binding studies
reported K(i values ranging from 2400 - 4000 nM and Bmax values ranging
from 75000 - 336000 fmol/mg protein (Foster and Fagg 1984). A more recent
autoradiographic study utilizing D-[3H]aspartate has characterized a Na+dependent binding site with a Kd

= 577 nM and a Bmax = 3710 fmol/mg

protein (Anderson et al. 1990). Anatomical heterogeneity in L- and D-TBH
inhibition of D-[3H]aspartate binding has suggested that two distinct
population of Na+-dependent binding sites may exist (Anderson and Vickroy
1990). The process of glutamate uptake into the cell is electrogenic. When a
single glutamate anion is transported into a cell, it is accompanied by the
simultaneous uptake of three Na+ ions while one K+ ion is transported out
of the cell (Barbour et al. 1988; Brew and Attwell 1987). Because one positive
charge enters the cell for every glutamate taken up by the carrier, an inward
current is generated. The second class of uptake sites, the CI--dependent sites,
are not as numerous as the Na+-dependent sites. Saturation analysis of
[3H]glutamate binding in the presence of c1- yield a binding site with a Kd
315 nM and Bmax

=

= 656 fmol/mg protein (Anderson et al. 1990). Binding at

this site is most potently inhibited by L-glutamate, L-a-amino adipic acid,
quisqualate, and L-serine-o -sulfate.
In addition to the Na+ and c1--dependent glutamate uptake sites
present on the plasma membrane, uptake sites for glutamate are present on
synaptic vesicles. Uptake at these sites is Na+-independent but potentiated by
the presence of c1-. These binding sites have an affinity for glutamate in the
millimolar range (Km = 2mM) and do not transport aspartate or other
glutamate analogues (Carlson et al. 1989).
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Glutamate Induced Neurotoxicity
Excitotoxicity, now a well known property of glutamate, was first
reported by Lucas and Newhouse (1957), when it was demonstrated that large
amounts of glutamate injected subcutaneously in mice caused extensive
retinal damage. The process of L-glutamate induced cell death is believed to
be mediated by several different mechanisms initiated by the binding of
glutamate to the NMDA, kainate, and possibly AMPA receptors. One
mechanism for this unique type of neurotoxicity, which damages only
neuronal cell bodies and not axons of passage, is believed to be an excess
influx of Ca 2+ into cells that results in the stimulation of various Ca2+
dependent proteases (Choi 1987). Others have suggested that a passive influx
of c1- ions may be responsible for the associated cell swelling and death
(Olney et al. 1986; Rothman 1985). Still more recently Coyle and collegues
have suggested that glutamate induced neurotoxicity may be mediated by
oxidative stress (Murphy et al. 1989). Excitatory amino acids have been
suggested to play a role in such neurodegenerative diseases as Huntington's
chorea (McGeer and McGeer 1976), epilepsy (Sloviter 1983), lathyrism
(Spencer et al. 1986), and Alzheimer's disease (Greenamyre and Young 1989).
Attenuation of glutamate induced neuronal damage has been demonstrated
with the use of both competitive and non-competitive glutamate antagonists
(Boast et al. 1988; Woodruff et al. 1987).
Excitatory Amino Acid Modulation of Noradrenergic/
Pineal Function
A novel function for excitatory amino acids was first suggested by
Baudry and collegues who noted that glutamate and its analogues inhibited
carbachol and histamine induced [3H]inositol phosphate accumulation in the
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hippocampus (Baudry et al. 1986). A similiar observation was made in
prefrontal cortex (Noble et al. 1989). NE-induced inositol phosphate
production did not appear to be inhibited by glutamate. It was noted by
others, however, that if the assay was modified and glutamate was added
prior to the incorporation of [3H]inositol into the larger phospholipid
molecule, glutamate could the NE-stimulated synthesis of [3H]IP3 (Jope and Li
1989). How glutamate inhibits this norepinephrine induced synthesis is not
known, but a reduction in the number of a1-adrenergic receptors, known to
mediate the NE-induced IP3 production, does not appear responsible for this
decrease (Nicoletti et al. 1986). In agreement with the observation that
glutamate decreases NE-induced phosphoinositide hydrolysis, it has been
demonstrated in vitro that SNAT activity can be decreased by the addition of
glutamate to NE-stimulated pineal glands (Govitrapong and Ebadi 1988). The
recent observation that photoreceptors (from which mammalian pinealocytes
evolved) release glutamate upon stimulation suggests a possible feedback
mechanism that can be applied to the pineal gland (Copenhagen and Jahr
1989).
This dissertation, which hypothesizes a neuromodulatory role for
glutamate in pineal gland function, examines several aspects of glutamate pineal gland interaction. In the first series of experiments, the amino acid
content of the pineal gland over the 24 hour light-dark cycle is examined.
The effect of sympathetic denervation on amino acid content within the
gland was assessed to determine if maintenance of amino acid content was
dependent on an intact innervation. Anatomical localization of glutamate
within the pineal gland was determined with the use of semiquantitative
imm unocytochemistry.
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In the second series of experiments the presence of a binding site for
[3H]glutamate in pineal gland was ascertained with the use of in vitro
receptor autoradiography. To determine if binding sites were located on
either sympathetic terminals or other pineal gland cell types, [3H]glutamate
binding was also examined in sympathetically denervated pineal glands. Day
-night differences in [3H]glutamate binding site number was determined by
examining [3H]glutamate binding in pineal glands obtained from animals
sacrificed during the middle of the light and dark periods.
The third series of experiments examines the effect of glutamate and
various glutamate agonists on the adrenergic-stimulated secretion of the
pineal gland hormone melatonin in vitro.

CHAPTER III

PINEAL GLAND AMINO ACIDS IN THE RAT I.
IMMUNOCYTOCHEMISTRY AND CIRCADIAN BIOCHEMICAL ANALYSIS
AFTER SUPERIOR CERVICAL GANGLIONECTOMY

Abstract

Semiquantitative immunocytochemistry was employed to determine
the anatomical distribution of glutamate- and glutamine-like
immunoreactivity within the pineal gland of the rat. The greatest amount of
glutamate- and glutamine-like immunoreactivity was found over
pinealocytes and glia respectively. At the subcellular level, glutamate-like
immunoreactivity was highest over pinealocyte mitochondria and lowest
over lipid inclusions. Pineal levels of glutamate and glutamine as measured
by high performance liquid chromatography (HPLC), did not vary over a
light-dark cycle. Superior cervical sympathetic denervation, which abolishes
pineal gland melatonin synthesis, resulted in a nearly 50% reduction in
pineal glutamate levels, but had no effect on levels of glutamine and taurine.
Other amino acids (alanine, arginine, aspartate, serine) were reduced between
16-36% following sympathectomy.
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Introduction
The mammalian pineal gland, a transducer of photoperiodic
information, synthesizes and secretes the hormone melatonin in highest
quantities at night (Klein and Weller 1970). The rate-limiting enzyme in the
synthesis of melatonin, SNAT, is activated by the nocturnal release of the
neurotransmitter NE from sympathetic nerve terminals located within the
pineal gland. Activation of this enzyme leads to the conversion of the
indoleamine serotonin (SHT) to N-acetylserotonin. A second enzyme,
hydoxyindole-O-methyltransferase subsequently methylates NAS to form the
methoxyindole, melatonin (Klein 1985). The resulting circadian rhythms in
these indole derivatives are driven by clock mechanisms in the SCN and are
dependent on an intact sympathetic innervation (Moore 1978).
Recently, numerous other factors have been implicated in the control
of melatonin synthesis and secretion. In addition to monoamines (Ebadi and
Govitrapong 1986), neuromodulatory peptides such as vasoactive intestinal
peptide (VIP), neuropeptide Y (NPY), vasopressin (VP) and oxytocin (OT)
have varying effects on SNAT activity and melatonin secretion (Olcese 1991;
Simonneaux et al. 1990; Simonneaux et al. 1990; Stehle et al. 1991). Levels of
OT and VP, as well as other neuropeptides such as somatostatin and an
immunoreactive arginine vassopressin-like peptide have been reported to
vary with time and/ or physiological status of the pineal gland implying a
functional relationship to melatonin synthesis (Liu and Burbach 1987; Liu
and Burbach 1988; Moujir et al. 1990; Webb et al. 1984). These observations
clearly indicate that the mechanisms regulating synthesis and secretion of
melatonin in the pineal gland are complex and multifaceted.
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To date, little information is available on a possible role for
neuroactive amino acids in modulating melatonin synthesis/secretion in the
pineal gland. Two such amino acids, glutamate and taurine, are present in
high concentrations within the pineal (Govitrapong and Ebadi 1988; McNulty
et al. 1990; Nir et al. 1973), and glutamate binding sites have been
characterized in the gland (Govitrapong et al. 1986; Kus et al. 1990).
Administration of glutamate to glands in vitro inhibited adrenergic receptor
activation of SNAT and melatonin secretion (Govitrapong and Ebadi 1988;
Kus et al. 1991). Taurine has also been shown to affect SNAT activation by
adrenergic mechanisms, but in a stimulatory fashion (Wheler et al. 1979). An
hypothesized functional relationship of these neuroactive amino acids with
adrenergic-mediated indole metabolism was further suggested by
developmental changes in day-night levels of amino acids coincident with
the ontogenetic onset of circadian rhythms in indole constituents leading to
the production of melatonin (McNulty et al. 1990).
The purpose of this investigation was to provide semiquantitative
immunocytochemical data on the distribution of glutamate and glutamine
within the different cellular compartments of the rat pineal gland. The
subcellular localization of glutamate within pinealocyte organelles was also
analyzed. A second aim of the study was to determine if steady state levels of
free amino acids exhibit circadian rhythms. In view of the above cited studies
suggesting an interaction of glutamate with adrenergic receptor mechanisms,
we also investigated the effects of sympathetic denervation on amino acid
levels over the 24 hour light-dark cycle.
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Materials and Methods

Animals
A total of 112 adult male Sprague-Dawley rats (Sasco-King, Oregon, WI)
were used in this study. Animals were housed in a fully accredited animal
care facility and were used according to the recommendations in the Guide

for the Care and Use of Laboratory Animals and The Guidelines of the
Institutional Animal Care and Use Committee at Loyola University Medical
Center. All animals were entrained for 4 weeks to programmed light:dark
cycles in the animal room (1000 lux) or in environmental chambers
illuminated by Vita lights (2200 lux) connected to automatic 24 hour timers.
Temperature in the environmental chambers was regulated by fans. All
animals had access to food and water ad libitum. For the experiments
measuring effects of denervation of pineal free amino acids, animals (n=6 per
time point per group) were sacrificed by rapid decapitation at 6 time points
over the light:dark cycle (mid-light, mid-dark, and 1 hour either side of lights
on and lights off). A dim red light (Kodak filter 1A) was used for dark-time
sampling. Animals used for immunocytochemical analysis were sacrificed by
cardiac perfusion after sodium pentobarbitol anesthesia.

Superior Cervical Ganglionectomy · Procedures
For bilateral removal of the superior cervical ganglia, animals (n=36)
were anesthetized with sodium pentobarbitol (65 mg/kg), placed in an aseptic
surgical field, and a ventral midline incision made on the neck. The carotid
sheath and contents were exposed and the sympathetic chains followed
rostrally to the superior cervical ganglia (SCG). The ganglia were removed
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bilaterally with fine forceps and micro-scissors and the incision closed with
sterile silk suture. Sham operations (n=36) involved all of the above except
removal of the ganglion. An additional unoperated control group (n=36) was
included in the study. A 4 week recovery period from the surgery was
allowed and the animals checked for ptosis to confirm superior cervical
ganglionectomy (SCGX). Individual glands were also assayed for
norepinephrine by HPLC (see below) to further confirm degeneration of
noradrenergic terminals.

High Performance Liquid Chromatography (HPLC)
General methods for HPLC have been described elsewhere (McNulty et
al. 1987; McNulty et al. 1990). Briefly, pineal glands were quickly dissected,
frozen on dry ice, and stored at -70°C until assayed. Glands were
homogenized in cold 0.05 M monobasic phosphate buffer (pH 7.0).
Homogenates were centrifuged at 15,000X g for 2 minutes and aliquots of
supernatant were injected directly into the chromatographic system
consisting of a Rainin Rabbit pump, a Rheodyne 7125 inject port with a 100
ml sample loop, and a C18 reverse phase column (10 cm X 4.6 cm, 3 mm
particle size, Rainin Instruments, Woburn, MA). Levels of free amino acids
were determined using pre-column derivatization with o-phthaldialdehyde
(OPA; Sigma) as described previously (McNulty et al. 1990). Fluorescence
emitted by the derivatized compounds was measured with a LDC
Fluoromonitor III (Milton Roy, Riviera Beach, FL) equipped with standard
excitation (340-380 nm) and emission (418-700 nm) filters. The detector was
connected to a HP 3390A integrator (Hewlett Packard, Avondale, PA) used to
analyze the peaks. The mobil phase consisted of 0.1 M monobasic sodium

43
phosphate mixed with HPLC-grade methanol (32 %) and delivered at a rate of
1.0 ml/min. A separate chromatograph was used to measure pineal levels of
NE as described previously (McNulty et al. 1990). Briefly, NE was separated
using a C18 reverse phase column and electrochemically detected with a
glassy carbon electrode (0.7 V vs Ag/ AgCl reference electrode) connected to a
BAS LC-4B electrochemical transducer. The mobil phase comprised 0.1 M
sodium phosphate with 3 mM octanesulfonic acid (Kodak) and 4% methanol
delivered at 1.0 ml/min with a 110A Altex metering pump. Identification of
eluted compounds were based on retention times, and the concentration of
samples were determined by comparison with synthetic standards made daily
from stock solutions. Aliquots of supernatant were reserved for the
measurement of soluble proteins according to the method of Lowry et al.
(1951).

Quantitative Electron Microscopic Immunocytochemistry.
Electron microscopic imm unocytochemistry of amino acids followed
previously published procedures (Ji et al. 1991; Ottersen 1988; Somogyi et al.
1986; Storm-Mathisen and Ottersen 1990). Animals (n=4) were anesthetized
with pentobarbital (65 mg/kg) during the middle of the photoperiod and
perfused through the left cardiac ventricle with the fixative solution
comprising 2.5 % glutaraldehyde and 1 % paraformaldehyde in 0.1 M sodium
phosphate buffer (pH 7.4). The fixative perfusion was preceded by a brief
flush of a 2% solution of dextran (MW 70,000) in the same buffer. After
dissecting the glands, they were postfixed in the
glutaraldehyde/paraformaldehyde fixative for 3 hours before post-fixation for
1 h with 1 % osmium tetroxide in phosphate buffer. Glands were
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subsequently dehydrated in ethanol and propylene oxide, then infiltrated and
embedded in epoxy resin (Durcupan). Ultra-thin sections (70-80 nm) were cut
with a diamond knife and mounted on Ni mesh grids for post-embedding
immunocytochemical procedures. Sections treated with periodic acid and
sodium periodate were exposed to the primary antisera, diluted 1:500. The
sera had been raised against either glutamate (code 03; (Ji et al. 1991)), or
glutamine (code 34; (Laake et al. 1986)) coupled to carrier protein by
glutaraldehyde following the procedure originally described by StormMathisen et al. (Storm-Mathisen et al. 1983). The secondary antibodies were
coupled to 15 nm gold particles. The specificity of labelling was monitored in
each experiment by analysis of test sections (Ottersen 1987) that had
accompanied the tissue sections throughout the immunocytochemical
procedures. These test sections carried model conjugates prepared by reacting
different amino acids with brain protein in the presence of glutaraldelhyde.
Each antiserum reacted selectively with the amino acid used for
immunization as demonstrated in a series of previous reports (Ji et al. 1991;
Ottersen 1988). As a further specificity control the antisera were preadsorbed
with their respective antigens. This was done by adding 400 uM
glutaraldehyde complexes of either glutamate or glutamine to the appropriate
antiserum on the day before the immunocytochemical incubation (Ji et al.
1991; Ottersen 1988). This procedure reduced the gold particle density over
the tissue to a level similar to that over tissue-free resin. Labelling was also
abolished when a pre-immune serum was used in lieu of the primary
antiserum.
Micrographs of the sections were made with an Hitachi H-600 electron
microscope at primary magnifications of 8,000X and 20,000X. Counts of the
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area densities of gold particles over specific cell compartments were obtained
by computerized image analysis using a Mac Hex running NIH Image
software. The freehand-selection tool was used to obtain profile areas of
specific cellular compartments and the number of gold particles counted
within that profile area after thresholding the gray-scale to include only the
electron dense gold particles. From 10-50 profiles of each cell type were
analyzed at 8,000X with 5-10 areas measured in each profile. Additional
measurements of area density of gold particles in mitochondria, cytoplasm
(n=22) were obtained from micrographs taken at 20,000X. Area densities for
pinealocyte cytoplasm and mitochondria obtained from low and high
magnification micrographs did not differ significantly.

Statistics
Means and standard errors of amino acid levels were calculated and
grouped according to treatment and time of sacrifice. The F-statistic for the
effect of time was calculated using a one-way ANOV A followed by Bonferroni
simultaneous confidence intervals. The F-statistic for the effect of time and
treatment was calculated using a two-way ANOVA. For
immunocytochemical data the F-statistic between groups was calculated using
a one-way analysis of variance. A p <0.05 was considered significant.
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Results

Pineal Gland Free Amino Acids and Protein

Circadian analysis
Estimates of the steady state levels of free amino acids in the pineal
gland of rats entrained to a 10:14 hour light-dark cycle revealed that glutamate
and taurine occurred in the highest concentrations (Table 1). Only one of the
amino acids assayed, alanine, exhibited significant differences over the lightdark cycle (Fig. 1 and Table 2). Steady state levels of other amino acids assayed
(glutamate, taurine, glutamine, aspartate, arginine, and serine) did not vary
significantly over the 24 hour light-dark cycle (Figs. 2, 3 and Table 2). There
were no differences in protein content of the glands related to time of sacrifice
over the light-dark cycle (data not shown).

Effect of SCGx
Variables from sham operated animals were not significantly different
from unoperated controls at any time point based on two-way ANOVA. Data
points from both the control and sham operated animals did not differ
significantly and the data were therefore combined (Table 1). Bilateral SCGx
significantly decreased pineal levels of glutamate, aspartate, alanine, and
arginine over the light-dark cycle (Figs. 1, 2 and Table 3). Sympathetic
denervation of the gland had the greatest effect on glutamate, decreasing
levels by 48% for samples pooled over the light:dark cycle. By comparison,
levels of aspartate, alanine, and arginine were decreased to a lesser extent (1636%) following SCGx, while the levels of serine were only marginally affected
(p=0.10) and glutamine, taurine, and protein were unaffected by denervation
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(fig. 3 and Table 3). Sympathectomy also abolished the circadian changes in
pineal alanine content (Fig. 1). NE levels were not detectable in any of the
sympathectomized glands (data not shown).

Immunocytochemistry

Glutamate
Specific immune-staining for glutamate was found in each of the cell
types present within the pineal gland (Figs. 4, 6). Semi-quantitative analysis
of gold particle densities revealed the highest concentration of glutamate
immuno-staining over pinealocytes (Figs. 4, 6). The densities of glutamate
immunolabelling did not differ significantly between glia, endothelia and
sympathetic nerve elements. Analysis of the subcellular cytoplasmic
distribution of glutamate-immunolabel within pinealocytes indicated that
lipid inclusions were nearly devoid of glutamate immunolabeling and
mitochondria had slightly higher label density compared to the surrounding
cytoplasm (Fig. 7).

Glutamine
Specific glutamine immuno-staining had the highest area density of
label in glia, and was only slightly above background in neural elements (Figs.
5, 6). The overall density of label in each of cell types was lower than that of
glutamate.
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Discussion

As it is in other brain regions, glutamate is present in high
concentration within the rat pineal gland. Immunocytochemically localized
within all cell types present in the gland, glutamate is likely to have several
functions. In addition to being a reaction product of the citric acid cycle,
glutamate is involved in the detoxification of ammonia, and serves as a
precursor for the synthesis of glutathione, proteins and GABA (Meister 1979).
The presence of these high levels of glutamate in the rat pineal gland may
also be related to the gland's phylogenetic transition from a photoreceptive
organ. Comparative anatomical and histochemical studies have presented
strong evidence that mammalian pinealocytes have evolved from
photoreceptors (Collin and Oksche 1981; Oksche 1965). It is not surprising
then that glutamate, which is a putative neurotransmitter in retinal
photoreceptors (Copenhagen and Jahr 1989; Ulshafer et al. 1990), is found in
high concentrations in pinealocytes. It has been recently demonstrated that
glutamate, which is released from photoreceptors (Copenhagen and Jahr 1989)
and activates second order neurons in the retina, can also influence
photoreceptors directly by binding to an autoreceptor and depolarizing the cell
(Sarantis et al. 1988; Tachibana and Kaneko 1988).
A role for glutamate in the mammalian pineal gland is suggested by
evidence for a specific binding site for this amino acid. Using [3 H]glutamate
as a ligand, a single, saturable and stereospecific binding site has been
characterized in both bovine and rat pineal gland (Govitrapong et al. 1986;
Kus et al. 1990). Although the precise function of this binding site has yet to
be elucidated, there is evidence that glutamate modulates the adrenergic
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activation of melatonin synthesis and secretion in an in vitro system
(Govitrapong and Ebadi 1988; Kus et al. 1991).
Because the mammalian pineal gland synthesizes and secretes
melatonin in highest concentrations at night in vivo, the presence of
compounds that modulate this process in vivo might also be expected to
possess a similar 24 hour rhythm in the gland. The question of a circadian
rhythm in glutamate concentration in the pineal gland was examined by
measuring glutamate concentration in the gland over the 24 hour light-dark
cycle. It was observed that glutamate levels do not change over the 24 hour
light-dark cycle, a finding that can be interpreted several ways. It is possible
that glutamate may be released from sympathetic nerve terminals in the
gland in a tonic manner. Changes in the glutamate concentration over the 24
hour light-dark cycle would therefore not be evident. It is also possible that
glutamate may be released in very small quantities. Because nerve terminals
make up such a small percentage of total pineal gland area, even concentrated
amounts of glutamate released by nerve terminals may not be detected within
the total pool of glutamate of approximately 2000 ng/gland. NE, for example,
only increases from 2.3 ng/gland during the day to 4.7 ng/gland at night (Craft
et al. 1984). In addition, glutamate is involved in general metabolism and if
released from nerve terminals may not remain as free glutamate within the
tissue for a long period of time. It may be immediately shunted by the cells
into some other metabolic process such as protein or glutathione synthesis. It
is also possible that glutamate is removed from the cell by its uptake carrier
because it has been shown that even highly concentrating uptake systems can
transport amino acids out of a cell (Van Winkle 1988).
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An alternative explanation for the lack of a 24 hour rhythm in the
glutamate content of pineal gland is that glutamate is not released fromsympathetic nerve terminals, which are responsible for the cyclic release of
NE in the gland. This is supported by the fact that immunocytochemical
localization of glutamate does not show this amino acid to be highly
concentrated within nerve terminals. It is interesting to note, however, that
removal of sympathetic nerve terminals by means of sympathectomy, results
in a significant decrease in the amount of glutamate present (48%) within the
gland. This might be expected if the SCG is the source of "transmitter"
glutamate. The effect of sympathectomy, however, was not specific for
glutamate as alanine, aspartate, arginine and serine were also decreased,
although to a lesser extent (16-36%).
In view of the fact that amino acids are an essential component of
intermediary metabolism, an effect of denervation on their content within
the pineal gland was not unexpected. Sympathectomy, for example, is known
to inactivate the indole biosynthetic pathway. Although it is unlikely that
almost half the steady state levels of glutamate is required for cellular
mechanisms leading to the synthesis and secretion of melatonin, it is difficult
to say with much certainty that the loss of pineal gland glutamate after
sympathectomy is due to loss of a transmitter pool located within sympathetic
nerve terminals. It is possible that uptake of these amino acids, which in the
case of glutamate occurs against a concentration gradient, is somehow
inhibited by sympathetic denervation. It is known, for example, that the
movement of one glutamate and three Na+ into the cell, while one K+ exits
the cell requires the maintenance of the Na+ /K+ concentration gradient
(Barbour et al. 1988; Brew and Attwell 1987). The observation that NE
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stimulates Na+ /K+- ATPase activity in rat brain in vivo (Swann and Steketee
1989) suggests that inhibition of the Na+ /K+ pump by denervation could affect
amino acid uptake.
The present data suggest that the decline in pineal glutamate was not
related to a general effect of denervation on pineal metabolism because
several other amino acids (glutamine, taurine, serine) were either unaffected
or marginally decreased following sympathectomy. Soluble protein content
was also unchanged after denervation, which is in good agreement with the
findings of Moore and Rapport (1971) that ganglionectomy had no effect on
pineal protein after 30 days.
Glutamine, another important amino acid in intermediary
metabolism, is believed to be in dynamic equilibrium with glutamate in
nervous tissue where glutamine is partitioned principally within glia. Our
immunocytochemical data suggest that a similar glial partitioning of
glutamine exists in the pineal gland. Compartmentilzation of glutamate and
glutamine is believed to be an important mechanism for separating metabolic
regulation of these amino acids in neural functions (Nicklas et al. 1987). The
present observation that pineal glutamine levels were not affected by
denervation suggests that the effects of sympathectomy are specific and
confined primarily to pinealocytes. The subcellular localization of glutamate
within pinealocytes is similar to that seen in neurons (Torp et al. 1991).
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Fig. 1. Alanine content of rat pineal gland over the 24 hour
light-dark cycle. Alanine values expressed as mean± SEM
are significant higher at 0+7 compared to other time points
(p<0.05 Bonferroni). Control and sham operated groups did
not differ significantly (p<0.77 ANOV A) and were combined.
n = 12 pineal glands per group per time point. Ganglionectomy
significantly decreased alanine level compared to control and
sham values (p<0.01 ANOV A). n = 6 pineal glands per group
per time point.
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Fig. 2. Glutamate content of rat pineal gland over the 24
hour light-dark cycle. Glutamate levels are expressed as
mean + SEM. Control and sham operated groups did not
differ significantly (p<0.92 ANOV A) and were combined.
n = 12 pineal glands per group per time point. There was
no significant differences in glutamate concentrations over
the light-dark cycle (p<0.09). Ganglionectomy significantly
decreased glutamate levels compared to control and sham
operated values (p<0.01 ANOVA). n = 6 pineal glands per
group per time point.
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Fig. 3. Glutamine content of rat pineal gland over the 24
hour light-dark cycle. Glutamine levels are expressed as
mean± SEM. Control and sham operated groups did not
differ significantly from one another and were combined.
n = 12 pineal glands per group per time. Ganglionectomy
did not effect glutamine content of the pineal gland. n = 6
pineal glands per group per time point.
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Fig. 4. Electron micrograph of pineal gland immuno-reacted for
glutamate illustrating parts of pinealocytes (P), a glial process (G),
noradrenergic neural elements (N) and endothelium (E). The
density of gold particles tends to be greatest over the pinealocytes.
Bar indicates 1.0 µM

•

Fig. 5. Electron micrograph of pineal gland immuno-reacted for
glutamine. Glia (G) are intensely labelled, and there is sparse labelling
over the neural element (N) in the perivascular space. P= pinealocyte
L = lipid droplet. Bar indicates 1.0 µM
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over cell compartments in the pineal gland after immuno
-staining for glutamate and glutamine. Gold particle density
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in pinealocytes and glia. Glutamate-like immunoreactivity
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Background represents particle density over the extracellular
compartment. n = 4 pineal glands.
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Table 1. This table compares amino acid content of pineal glands obtained
from control (C) and sham operated (S) animals. Means + SEM of amino
acids (ng/gland) in the rat pineal gland over the 24 hour light-dark cycle are
presented. Time is designated as hours after lights on (L) and hours after
lights off (D). n = 6 pineal glands for each group at each time point. P values
are based on F statistic for effect of treatment from a two-way ANOV A. A p<
0.05 was considered significant. Control and sham operated values do not
differ significantly in any of the amino acids. Control and sham values were
therefore grouped in later statistical analysis (See Tables 2 and 3).
L+l

L+S

L+9

0+3

0+7

0+11

Treat

p>F
Arg C

s
Asp C

s

Ala

C

s
Glu C

s
Gln C

s
Ser

C

s
Tau

C

s

359±60
548±55
434±94
565±70
178±22
228±21
1713±243
2448±150
1010±149
1289±90
471±109
411±56
1587±211
2279±217

532 ±126
498±116
388±47
479±110
200±14
182±21
2105±191
1873±255
1226±134
1034±141
412±41
398±44
2014±111
1886±243

601±124
711±95
499±95
473±85
241±40
206±25
2305±303
2342±243
1323±198
1335±104
651±185
484±127
2156±379
2670±408

623±89
551±80
401±60
446±132
189±33
199±35
2008±211
1765±296
1350±150
1140±158
371±22
408±63
1966±216
1800±341

549±99
677±86
396±88
397±102
284±33
313±40
1886±314
1949±187
1268±148
1189±130
474±66
397±121
1356±103
2005±320

489±61
480±88
293±56
215±35
268±26
204±28
1790±156
1472+283

1095±29
955±166
534±76
320±46
1974±171
1846±293

0.09
0.53
0.77
0.92
0.47
0.09
0.08
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Table 2. This table examines amino acid content of pineal glands over time.
Control and sham operated groups are combined as C/S. Values are
presented as means + SEM of amino acids (ng/ gland). Time is designated as
hours after lights on (L) and hours after lights off (D). P values are based on F
statistic for effect of time from one-way ANOVA. A p< 0.05 was considered
significant. Significant differences over time are seen only in alanine in the
C/S group. No differences over time in amino acid content was seen in any
ganglionectomized (G) group. n = 12 (C/S) or 6 (G) pineal glands for each
group at each time point.
L+l

L+S

L+9

0+3

0+7

0+11

Time

p>F

Arg

C/S

G

Asp

C/S

Ala

C/S

G
G

Glu

C/S

G

Gln

C/S

G

Ser

C/S

Tau

C/S

G
G

454±48
515±78
656±73
587±56
613±63
485±47
317±46
317±34
326±24
339±58
377±69
429±98
499±57
433±56
486±58
423±67
396±61
257±34
251±51
284±50
247±66
333±64
290±49
283±21
191±12
224±22
194±22
203±16
299±24
239±20
145±22
118±10
147±24
151±26
182±23
163±29
2080±174 1989±149 2324±177 1886±170 1917±167 1646±147
1005±214 851±98 1052±107 949±122 1068±171 1185±229
1150±91
1130±93 1329±101 1245±105 1228±90 1031±72
1123±113 988±148 1098±92 1072±142 1264±182 1322±242
441±57
435±64
427±55
405±27
567±105
389±31
441±42
326±69
449±109
355±36
317±25
356±35
2413±266
1933±176 1950±123
1883±185 1680±184 1916±146
1910±322 1693±181 1815±144 1705±178 1776±246 2083±410

0.13
0.67
0.05
0.82
0.01
0.54
0.09
0.78
0.26
0.66
0.34
0.56
0.11
0.88
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Table 3. This table compares amino acid content of pineal glands obtained
from control and sham operated (combined as C/5) with ganglionectomized
(G) animals. Means + SEM of amino acids (ng/ gland) in the rat pineal gland
over the 24 hour light-dark cycle are presented. Time is designated as hours
after lights on (L) and hours after lights off (D). n = 6 pineal glands for each
group at each time point. P values are based on F statistic for effect of
treatment from two-way ANOV A. A p< 0.05 was considered significant.
Significant differences between control and sham (C/S) and
ganglionectomized (G) groups were seen in arginine, aspartate, alanine and
glutamate but not in glutamine and taurine.
L+l

L+S

L+9

D+3

D+7

D+ll

Treat

p>F
Arg

C/S

G

454±48
317±46

499±57
G
251±51
C/S
203±16
Ala
G
145±22
Glu C!S 2080±174
G 1005±214

Asp C/S

Gln

1150±91
G 1123±113
Ser C/S 441±57
G
356±35

Tau

C/S

C/S

G

1933±176
1910±322

515±78
339±58
433±56
284±50
191±12
118±10
1989±149
851±98
1130±93
988±148
405±27
326±69
1950±123
1693±181

656±73
317±34
486±58
247±66
224±22
163±29
2324±177
1052±107
1329±101
1098±92
567±105
449±109
2413±266
1815±144

587±56
326±24
423±67
333±64
194±22
147±24
1886±170
949±122
1245±105
1072±142
389±31
355±36
1883±185
1705±178

485±47
613±63
377±69
429±98
396±61
257±34
290±49
283±21
299±24
239±20
151±26
182±23
1917±167 1646±147
1068±171 1185±229

0.01
0.01
0.01
0.01

1228±90
1264±182

1031±72
1322±242

0.66

435±64
317±25

427±55
441±42

0.10

1680±184 1916±146
1776±246 2083±410

0.34

CHAPTER IV

PINEAL GLAND AMINO ACIDS IN THE RAT II.
CHARACTERIZATION OF A [3H]GLUTAMATE BINDING SITE

Abstract
Glutamate, an excitatory neurotransmitter/ neuromodulator involved
in cell to cell communication within the central nervous system is now
believed to play a role in neuroendocrine function. In this study we describe
a single, saturable and stereospecific binding site for [3H]glutamate (Kci = 612 +
23 nM, Bmax

= 3170 + 330 fmol/mg protein). Binding of [3H]glutamate was

temperature, time, and pH-dependent. After removal of the sympathetic
innervation to the pineal gland, [3H]glutamate binding displayed a higher
appparent affinity

(Ki = 412 + 28 nM) (p<0.05 T-test) without a change in

binding site number (Bmax

= 3600 + 240 fmol/mg protein). No difference in

[3H]glutamate binding site number was observed in pineal glands obtained
from animals sacrificed during the middle of either the light or dark periods.
These data suggest a possible modulatory role for glutamate in pineal gland
function.
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Introduction

The excitatory amino acid (EAA) glutamate plays an important role in
both normal and pathological brain function. Acting via its AMPA, kainate,
and NMDA receptors, glutamate depolarizes postsynaptic neurons by opening
ion channels and allowing the influx of Na+ and Ca2+ (Asher and Nowak
1987; Hollmann et al. 1991). Glutamate also stimulates second messenger
production by interacting with a fourth receptor subtype, the metabotropic
receptor (Sladeczek et al. 1988). Activation of these receptors within the
central nervous system is believed to mediate such diverse phenomena as
learning (Lynch et al. 1990), visual plasticity (Dudek and Bear 1989), neuronal
differentiation (Mattson et al. 1988) and possibly cell death (Choi and
Rothman 1990). The recent observation that a majority of excitatory
neurotransmission within the neuroendocrine mediobasal hypothalamus is
mediated by glutamate (Van den Pol et al. 1990) also suggests that this amino
acid may play an important role in the regulation of neuroendocrine systems.
The pineal gland is an important component of the neuroendocrine
system regulating circadian rhythmicity. The release of NE from postganglionic sympathetic fibers originating in the superior cervical ganglion
(SCG) stimulates the production of the pineal hormone melatonin via its
binding to adrenergic receptors located on pinealocytes (Sugden 1989). The
pineal gland also possesses a number of other receptor types, including those
for benzadiazepine, dopamine, GABA and glutamate (Ebadi 1987). While the
function of these latter receptors is unclear, a possible role for glutamate in
pineal gland function of the rat has been suggested by several observations.
First, glutamate is found in relatively high concentrations in the rat pineal
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gland (McNulty et al. 1989). Second, glutamate has been demonstrated to
inhibit NE stimulated serotonin SNAT activity in the rat pineal in vitro.
(Govitrapong and Ebadi 1988). Due to the small amount of tissue present in
the rat pineal, however, identification of a glutamate binding site in this
species has not been made. Because the rat is an important animal model in
pineal gland research, the goal of this study was to identify and characterize a
glutamate binding site in the rat pineal gland with the use of in vitro
quantitative receptor autoradiography.
In addition, we have also examined several possible ways in which
pineal glutamate binding sites can be regulated. With regard to the
observation that steady state levels of glutamate can be markedly reduced by
SCGx (McNulty et al. 1989), it was important to ascertain the effects of
denervation on this binding site. Examination of [3H]glutamate binding after
SCGx was also expected to yield additional information about the location of
[3H]glutamate binding, i.e binding to pre- or post-synaptic sites. Finally,
because NE content, 13-adrenergic receptor density, and melatonin levels
exhibit significant differences over the light-dark cycle (Gonzalez-Brito and
Reiter 1987), pineals were examined for day vs night differences in glutamate
binding site number.

Materials and Methods

Chemicals
[3H]Glutamate (SA= 43-56 Ci/mmol) was obtained from Amersham
(Arlington Heights, IL). Quisqualate, CPP ((+/-) -3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid), and CNQX (6-cyano-7-nitro-quinoxaline-2,3-dione)
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were obtained from Research Biochemicals Inc. (Natick, MA). All other
compounds were obtained from Sigma Chemical Co. (St. Louis, MO).

Animals
A total of 64 adult male Sprague-Dawley rats (Sasco-King, Oregon, WI)
were used in this study. Animals were housed in a fully accredited animal
care facility and were used according to the recommendations in the Guide

for the Care and Use of Laboratory Animals and The Guidelines of the
Institutional Animal Care and Use Committee at Loyola University Medical
Center. All animals were entrained to a 12:12 hour light-dark cycle and had
access to food and water ad libitum. Animals were sacrificed by rapid
decapitation over the light:dark cycle at times specified in each experiment. A
dim red light (Kodak filter 1A) was used for dark-time sampling.

Superior Cervical Ganglionectomy Procedures
For bilateral removal of the superior cervical ganglia (SCG), animals
were anesthetized with pentobarbitol (65 mg/kg ip), placed in an aseptic
surgical field, and a ventral midline incision made on the neck. The carotid
sheath and contents were exposed and the sympathetic chains were followed
rostrally to the superior cervical ganglia. The ganglia were removed with fine
forceps and micro-scissors and the incision closed with sterile silk suture. A 4
week recovery period was allowed.

Autoradiography
Following sacrifice, pineal glands were rapidly removed and frozen on
dry ice. Tissue was subsequently placed in embedding matrix for support and
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sectioned with a Leitz (Model II) cryostat at a thickness of 10-14 µm. Sections
(3-4) were placed on the ends of individual gel coated slides and frozen at 700c overnight. A single pineal yielded 50-60 sections, enough for a complete
saturation or competition curve. The tissue was preincubated in 0.05M Tris
acetate buffer, pH 7.2 at 4°C for 20 min. Sections were dried with a stream of
cool air and incubated at 4°C for 60 min in Tris buffer with increasing
concentrations of L-[3H]glutamate (further referred to as [3H]glutamate) (25
nM-800 nM). Non-specific binding was determined by addition of 1000 fold
excess non-radioactive glutamate and was subtracted from total binding to
determine specific binding. Competition assays to determine receptor
subtypes utilized a single concentration of [3H]glutamate (200 nM) and
increasing concentrations of various non-radioactive compounds (25 nM-200
mM). To terminate the binding reaction, sections were rinsed in ice cold Tris
acetate buffer for 2 minutes with 1 buffer change. Sections were rapidly dried
under cool air and placed in X-ray cassettes with appropriate radioactive
standards (Microscales, Amersham). Tissue was apposed to tritium sensitive
Hyperfilm (Amersham) for 3-6 weeks at 4°C. The film was developed in fresh
Kodak D19 for 5 minutes, fixed, rinsed and dried. Autoradiograms were
analyzed by computer assisted microdensitometry (RAS 5000 system,
Amersham). Bound radioactivity was determined by a computer generated
polynomial regression analysis which compares film densities produced by
pineal sections with those produced by tritium standards. Saturation data
were analysed according to the method of Scatchard (Scatchard 1949). Ki
values were calculated from ICso values using the equation of Cheng and
Prusoff: Ki = ICso/ (1 + [3H-Glu] /

Ki) (1973).
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fila tis tics
Statistical analysis of the data was performed with the Student's t-test.

Results

Binding Assays

[3 H]Glutamate binding in intact animals
Saturation analysis of [3H]glutamate binding revealed a single binding
site with a Hill coefficient= 0.932

± 0.028 (Fig.

2), an apparent dissociation

constant (Kd) of 612 ± 23 nM and a Bmax of 3170 + 330 fmol/mg protein (Fig.
1). Binding was time, temperature, and pH dependent with optimal
conditions at 60 minutes (Fig. 3), 4°C (Fig. 4), and pH 7.2 (Fig. 5). Various
glutamate agonists and antagonists demonstrated a range of competition for
bound [3H]glutamate. L-Glutamate was the best competitor with a Ki value of
536 + 37 nM (Fig. 6), while the D-isomer was inactive. Quisqualate displayed
moderate inhibition of binding with a Ki value of 34000 + 5500 nM (Fig. 7).
All other compounds tested were inactive (Table 1).

Mid-light vs mid-dark [3 H]glutamate binding
Specific [3H]glutamate binding in the pineal gland of animals entrained
to a 12:12 hour light-dark cycle and sacrificed during the middle of the dark
period did not differ significantly from binding observed in pineals obtained
from animals sacrificed during the middle of the light period (Fig. 8).
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[3 H]Glutamate binding in SCGx animals
SCGx was confirmed in all animals by the presence of ptosis bilaterally.
Saturation analysis of [3H]glutamate binding in this group demonstrated a
single binding site with a Hill coefficient of 0.987 + 0.021, a KcI of 412 + 28 nM
and a Bmax of 3600 + 240 fmol/mg protein. Sympathectomized pineal glands,
when compared to intact controls, possessed a higher apparent affinity for
[3H]glutamate binding (p<0.05) without a change in binding site number (Fig.
9).

Discussion

In this paper, we describe a single, saturable, stereospecific,
temperature, time, and pH-dependent binding site for glutamate in the pineal
gland of the rat which has not been previously characterized. Our values are
consistent with values reported by other investigators for glutamate binding
in other brain regions (Cincotta et al. 1989; Fagg et al. 1983) as well as in the
bovine pineal (Govitrapong et al. 1986). Interestingly, the only compound
that demonstrated a relatively high affinity for [3H]glutamate binding was Lglutamate itself. While quisqualate inhibited [3H]glutamate binding, the high
Ki value of 34000 + 5500 nM (relative to that observed for quisqualate
inhibtion in other brain regions), suggests that it is unlikely that this
corresponds to the functional quisqualate/ AMPA receptor described in other
brain regions. Contamination of quisqualate by L-glutamate is believed to be,
in part, responsible for this low affinity component of quisqualate binding
(Cha et al. 1989).
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It should be noted that the binding of [3H]glutamate in tissue can

represent binding to several membrane components, including receptors
linked to ion channels/second messenger systems, uptake sites, and enzymes.
In addition, sequestration of ligand by lipid vesicles within tissue can occur.
To minimize the possibility of [3H]glutamate uptake, the present saturation
and competition studies were performed in sodium, chloride, and calciumfree buffer. No inhibition of [3H]glutamate binding was observed in the
presence of D-aspartate, an amino acid with relatively high affinity for the
Na 2+-dependent glutamate uptake site. The possibility that [3H]glutamate
may have bound to an enzyme similiar to the one responsible for the
cleavage of the endogenous peptide N-acetyl-aspartyl-glutamate (Slusher et al.
1990; Stauch et al. 1989) is not likely for several reasons. First, as outlined by
Slusher et al. (1990) and Stauch et al. (1989), this enzyme, N-acetylated-alphalinked acid peptidase (NAALA dipeptidase), has been demonstrated to have a
much higher affinity for quisqualate than L-glutamate. We have observed
the opposite rank order for these 2 compounds in the pineal gland. Second,
NAALA dipeptidase appears to have an absolute requirement for chloride for
its activation and we did not include chloride in our incubation buffer.
Third, binding of [3H]glutamate in this study was greater at 4°C than at 37°C,
not a common feature of enzyme-substrate interactions. While the type of
glutamate binding site present in the rat pineal gland is not clear, it does not
appear to be one of the major glutamate receptor subtypes (AMPA, kainate, or
NMDA) as even high concentrations of competitor did not inhibit
[3H]glutamate binding. It is possible that this binding site is similar to the
Na 2 + and Cl--independent glutamate binding site described in the
neurohypothysis (Yoneda and Ogita 1989). Glutamate binding at this site
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possesses a Kd = 340 nM and is sensitive to inhibition by quisqualate OCso =
56µM) but not other glutamate analogues. Dissimilarities, however, indude
the fact that binding site number increase if the tissue is incubated at 30°C
when compared to 2°C. Functional studies to examine the role of glutamate
on the adrenergic stimulated production of melatonin may help to elucidate
the role of glutamate in pineal gland function.
The observed increase in the affinity of [3H]glutamate binding after
SCGx without a corresponding change in receptor number may have been
due, in part, to a decrease in the amounts of endogenous ligand present after
SCGx. The intact pineal gland of the rat possesses relatively high levels of
glutamate that decrease by approximately 50% after SCGx (McNulty et al.
1989). It is possible that tissue preincubation may not have removed all the
free glutamate present within the tissue sections, thereby decreasing the
apparent affinity of [3H]glutamate binding in intact glands without altering
binding site number. A similar problem with contamination by L-glutamate
was noted in homogenous preparations of retinal membranes (Yoneda and
Ogita 1989).
Based on the observation that glutamate stimulates the release of
[3H]NE from synaptosomes prepared from hippocampus, olfactory bulb, and
cerebral cortex, it is believe that presynaptic receptor for glutamate are present
on noradrenergic terminals (Wang et al. 1992). The observation that receptor
number did not change after SCGx suggests that binding sites for
[3H]glutamate were located either on pinealocytes and/or astrocytes and not
on noradrenergic nerve terminals.
Unlike noradrenergic receptors (Pangerl et al. 1990), a day-night
difference in [3H]glutamate binding site number was not observed. In
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addition, the observation that glutamate levels in the pineal gland do not
vary over the light-dark cycle (McNulty et al. 1989) suggests that the role of
these binding sites may be tonic in nature. Previous demonstration of
glutamate's ability to inhibit the NE-induced production of inositol
phospholipids in various brain regions (Jope and Li 1989) suggests a
mechanism by which glutamate may interact with the adrenergic system to
inhibit melatonin production.
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Fig. 1. Saturation and Scatchard analysis of [3H]glutamate binding in rat
pineal glands. These studies, performed in c1-, Na+, and Ca 2+ free buffer,
utilized ligand concentrations between 25 nM and 800 nM. Non-specific
binding was determined by the addition of 1000 fold excess inert
glutamate. Each pineal gland provided a complete saturation curve. Six
pineal glands were analysed. Binding at each concentration of
[ 3H]glutamate was performed in triplicate. Ka= 612 + 23 nM, Bmax =
3170 + 330 fmol/mg protein.
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Table 1. Inhibition of [3H]glutamate binding (100 - 300 nM) in rat pineal
gland by various non-radioactive compounds. Data represent the means
± SEM of 3 - 5 inhibition curves (1 pineal gland/ curve). Ki values were
calculated from ICso values using the equation of Cheng and Prusoff (1973).
Number of pineal glands are shown in parenthesis.

Ki (nM)
L-Glutamate (5)

535 + 37

D-Glutamate (3)

>200000

Quisqualate (3)

34000±550

CNQX (5)

>200000

N-Methyl-D-Aspartate (4)

>200000

CPP (4)

>200000

Kainate (4)

>200000

D-Aspartate (4)

>200000

APB (3)

>100000

Taurine (3)

>200000

Melatonin (3)

>200000

Norepinephrine (3)

>200

CHAPTER V

GLUT AMA TE INHIBITION OF THE ADRENERGIC-STIMULATION
SECRETION OF MELATONIN IN THE RAT
PINEAL GLAND IN VITRO

Abstract

The effect of L-glutamate on the adrenergic stimulated release of
melatonin in the rat pineal gland was examined using an in vitro perifusion
system. L-Glutamate by itself had no effect on melatonin production while Lglutamate administered prior to (-)isoproterenol (~-adrenergic agonist) and Lphenylephrine (a-adrenergic agonist) inhibited melatonin production by 42
%. L-Glutamate did not inhibit melatonin production when glands were

stimulated with (-)isoproterenol alone. D-glutamate as well as the Lglutamate agonists, kainate, NMDA, quisqualate and trans-ACPD had no
effect on melatonin release. The possibility that L-glutamate may be
converted to another neuroactive compound (GABA) prior to the addition of
(-)isoproterenol and L-phenylephrine is suggested by the observation that
simultaneous administration of L-glutamate with (-)isoproterenol and Lphenylephrine did not inhibit melatonin secretion.
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Introduction
In the pineal gland of every mammalian species studied, the
autonomic nervous system plays a pivotal role in regulating the production
of the pineal hormone melatonin (Kappers 1965). NE released from the
postganglionic neurons of the SCG activates the rate limiting enzyme in
melatonin synthesis, SNAT, via its binding to a- and P-adrenergic receptors
(Klein et al. 1987). A number of other receptor types have been described in
the pineal gland including D2-dopaminergic, GABAergic, glutaminergic and
cholinergic, the functions of which are presently unknown (Ebadi et al. 1986).
The characterization of a binding site for L-[3H]glutamate in the pineal gland
of the rat (Kus et al. 1990) together with the observation that high amounts of
glutamate are normally present in the gland (Govitrapong and Ebadi 1988; See
Chapter IV) prompted the present investigation of the function of this
binding site.
Known to act as an excitatory neurotransmitter in most regions of the
central nervous system, glutamate has been reported to inhibit SNAT activity
in the pineal gland of the rat in vitro (Govitrapong and Ebadi 1988).
Inhibitory effects of glutamate are, however, rare (Mayer and Westbrook
1987). Accordingly, we examined the role of glutamate in pineal gland
function by testing the effects of various glutamate agonists on the adrenergic
stimulated secretion of melatonin in vitro.
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Materials and Methods

Chemicals
Quisqualate was obtained from Research Biochemicals Inc. (Natick, MA).
Trans-ACPD was a gift from D. Monaghan (Omaha, NE). All other compounds
were purchased from Sigma (St. Louis, MO).

Animals
A total of 58 adult (2 - 4 months) male Sprague-Dawley rats (Sasco-King,
Oregon, WI) were used in this study. Animals were housed in a fully accredited
animal care facility and were used according to the recommendations in the Guide

for the Care and Use of Laboratory Animals and The Guidelines of the Institutional
Animal Care and Use Committee at Loyola University Medical Center. All
animals were entrained to a 12:12 hour light-dark cycle (1000 lux). For all
experiments, animals had access to food and water ad libitum. Animals were
sacrificed by rapid decapitation during the middle of the light cycle.

Perifusion
All experiments were performed using an Acusyst-S-APS 10
programmable flow through perifusion sysytem (Endotronics, Coon Rapids,
MN). Glands were rapidly dissected and placed in ice cold oxygenated (95%

02, 5% CO2) artificial cerebral spinal fluid (CSF) (pH 7.3) during the sampling
period. Tissue was then transferred to the perifusion chamber (4X10 mm)
where prewarmed (37°C), oxygenated artificial CSF was delivered at a rate of
0.208 ml/minute or 0.037 ml/minute in experiments where LDH was assayed.
One pineal gland was placed in each chamber. Pineal glands were
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equilibrated by preincubation for a period of 4 hours at which time melatonin
output reached basal levels. Tissue was incubated in either the presence of ()isoproterenol (Iso) (10-5M-10-6M) and L-phenylephrine (PE) (10-5M-10-6M) or
L-glutamate alone (JO-3M) In experiments that examined the effect of
glutamate agonists on the Iso and PE-stimulated secretion of melatonin from
pineal glands, the following paradigms were used: L-Glutamate (5 X 10-6M - 5
X 10-3M) or D-glutamate (JO-3M) were administered to glands 4 hours after
the start of the experiment (4.0 hr) for 60 minutes followed by Iso (10-6M) and
PE (10-6M) at 5.0 hr for 25 minutes. Glutamate agonists, kainate, NMDA, and
guisqualate (10-4M), were administered to glands at 4.5 hour for 30 minutes
folowed by Iso (10-6M) and PE (10-6M) at 5.0 hr for 25 minutes. Trans-ACPD
(10-4M) was administered to glands at 4.0 hour for 30 minutes folowed by Iso
(10-6M) and PE (10-6M) at 5.0 hr for 25 minutes. D,L-APB (2 X 10-4M) was
administered to glands at 4.5 hour for 30 minutes folowed by Iso (10-6M) and
PE (10-6M) at 5.0 hr for 25 minutes. Mg2+ was omitted and glycine (10-6M) was
added to the buffer when experiments included NMDA because Mg2+ inhibits
and glycine potentiates the action of NMDA at its receptor. Samples of
perfusate were collected every 30 minutes by a fraction collector and stored at
4°C until assayed for melatonin content.

Radioimmunoassay
Artificial CSF obtained from in vitro perifusion studies was assayed for
melatonin with the use of a direct radioimmunoassay based on a modified
method of Fraser (Fraser et al. 1983 ). Briefly, samples (100µ1) were
incubated with antiserum (sheep antiserum 704-8483, diluted 1:30,000,
Guildhay, U.K.) and labeled ([3H] melatonin 81.1 Ci/mmol) overnight at 40c
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in tricine buffered saline (TBS) with 0.1 % gelatin (pH 5.5). Bound and free
melatonin were separated by the addition of a dextran coated charcoal
solution (2.5 g charcoal, 0.25 g dextran/1 TBS) to samples. Samples were
centrifuged at 1500 X G for 15 minutes and the supernatant decanted into
scintillation vials. Bound radioactivity was counted in a Packard tri-carb beta
scintillation counter. Unknown sample values were calculated from a
standard curve constructed from known amounts of melatonin (0 -100 pg).
Lower limit of sensitivity was 2.0 - 3.0 pg/tube. Intra-assay and inter-assay
coefficients of variability were 8.0% and 15% respectively.

High Performance Liquid Chromatography (HPLC) of Amino Acids
General methods for HPLC have been described elsewhere (McNulty et
al. 1987; McNulty et al. 1990). Briefly, pineal glands were quickly dissected,
frozen on dry ice, and stored at -70°C until assayed. Glands were
homogenized in cold 0.05 M monobasic phosphate buffer (pH 7.0).
Homogenates were centrifuged at 15,000X g for 2 mins and aliquots of
supernatant were injected directly into the chromatographic system
consisting of a Rainin Rabbit pump, a Rheodyne 7125 inject port with a 100 µl
sample loop, and a C18 reverse phase column (10 cm X 4.6 cm, 3 mm particle
size, Rainin Instruments, Woburn, MA). Levels of free amino acids were
determined using pre-column derivatization with o-phthaldialdehyde (OPA;
Sigma) as described previously (McNulty et al. 1990). Fluorescence emitted by
the derivatized compounds was measured with a LDC Fluoromonitor III
(Milton Roy, Riviera Beach, FL) equipped with standard excitation (340-380
nm) and emission (418-700 nm) filters. The detector was connected to a HP
3390A integrator (Hewlett Packard, Avondale, PA) used to analyze the peaks.
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The mobil phase consisted of 0.1 M monobasic sodium phosphate mixed with
HPLC-grade methanol (32%) and delivered at a rate of 1.0 ml/min.
Identification of eluted compounds were based on retention times, and the
concentration of samples were determined by comparison with synthetic
standards made daily from stock solutions. Aliquots of supernatant were
reserved for the measurement of soluble proteins according to the method of
Lowry et al. (1951).

Lactate Dehydrogenase (LDH) Assay
Secretion of LDH, an intracellular enzyme, was measured as an
indicator of cell damage or death using a colorimetric kit (Sigma). LDH in the
buffer catalyzed the following reaction: pyruvic acid+ NADH, lactic acid+
NAD. Unconverted pyruvic acid, when treated with 2,4dinitrophenylhydrazine, produces a phenylhydrazone that is highly colored.
LDH activity is inversely proportional to the absorbance of the color formed.
Absorbance was measured at a wavelength of 464 nm.

Statistics
All data points are presented as mean+ SEM. Data obtained from
experiments comparing melatonin and LDH release from control and
experimental pineal glands over time were analysed with a two-way ANOVA
with repeated measures. Total melatonin secreted from each gland 4.5 hours
to termination of experiment was calculated and means of control and
experimental glands were compared with a Student's T-test. Differences in
amino acid content of control and experimental pineal glands were analyzed
with a Student's T-test.
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Results

Stimulation of pineal glands by adrenergic agonists
Spontaneous release of pineal gland melatonin reached baseline (10-20
pg/min/gland) by 4 hours after the start of the experiment (Fig. 1). At this
time most drug admininstration was initiated. A similar time course for the
decrease in spontaneous melatonin release has been previously reported
(Simonneaux et al. 1989). This unstimulated release of melatonin from the
gland was most likely due to cell damage caused by removal of the gland from
the brain. LDH release, an indicator of cell damage, had a pattern similar to
spontaneous release of melatonin shown in Fig. 2. Differences in the initial
release of melatonin by pineal glands between experiments may be due to
differences in sampling time, i.e the amount of time glands remained in cold
buffer before being transferred to the perifusion apparatus. Pineal glands
were stimulated by lso and PE in a dose dependent manner (10-6 - 10-SM) with
a detectable increase in melatonin secretion approximately 1.5 hours after Iso
and PE administration (Fig. 3). Addition of PE (10-6M) to pineal glands did
not potentiate the 13-adrenergic-induced (Iso (10-6M) and prazosin (10-6M))
response (Fig. 4).

Effect of L-glutamate on melatonin production
L-Glutamate (10-3M) by itself neither stimulated the secretion of
melatonin nor significantly altered baseline levels (Fig. 5). L-Glutamate (l0-3
M) administered before lso (10-6M) and PE (10-6M) significantly inhibited
melatonin secretion (p<0.025 ANOVA), decreasing hormone concentrations
by approximately 42% (Fig 6). Lower doses of L-glutamate (5 X 10-6 Mand 5 X
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10-4 M) (Figs. 7, 8) had no attenuating effect. A higher dose of glutamate (5 X
10-3M (Fig. 9) did not significantly decrease melatonin secretion (p<0.065
ANOVA). D-glutamate (10-3M) was ineffective (Fig. 10).
Melatonin production stimulated by lso (10-6M) alone was not
inhibited by 1 hour pretreatment with L-glutamate (1Q-3M) (Fig 11). To assure
that the alpha-1 receptor was not activated during these experiments,
prazosin (10-6M), an a.1 antagonist was added to the artificial CSF. To rule out
any stimulatory effects of prazosin, the experiment was repeated, but without
the addition of prazosin (Fig. 12). L-Glutamate (1Q-3M), again, did not inhibit
the Iso (10-6M) stimulated secretion of melatonin.

Effect of L-glutamate agonists on melatonin secretion
Agonists of the four major glutamate receptor subtypes were assayed
for their ability to inhibit Iso (10-6M) and PE (10-6M) stimulated production of
melatonin. NMDA, kainate, quisqualate (100µM) (AMPA and metabotropic
receptors), D,L-APB (200µM) and trans-ACPD (100µM) (metabotropic receptor)
were all ineffective at attenuating the melatonin secretion stimulated by Iso
and PE (Figs. 13 -17).

Timing of L-glutamate administration
L-glutamate administered 2 hour before Iso and PE did not significantly
decreased melatonin secretion (p<0.42 ANOVA) (Fig. 18). Simultaneous
administration of L-glutamate and Iso and PE at 4.0 hour for 25 minutes did
not inhibit melatonin secretion (Fig. 19).
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Amino acid content of pineal glands administered L-glutamate
The only amino acid found to increase significantly in pineal glands
administered L-glutamate (IQ-3M) was L-glutamate itself, (p<0.02 T-test) (Fig
20). Glutamine levels in the tissue were somewhat higher(~ 27%) although
not statistically significant.

Discussion

The importance of glutamate as a neurotransmitter within the central
nervous system has been clearly established (Mayer and Westbrook 1987).
Only recently gaining recognition as a modulator of neuroendocrine function
in the mediobasal hypothalamus (Van den Pol et al. 1990), L-glutamate has
also been reported to stimulate the release of prolactin from pituitary glands
(Login 1990) and the release of catecholamines from isolated adrenal medulla
(Nishikawa et al. 1982). L-Glutamate in this study, while having no effect by
itself, inhibited melatonin production in adrenergically stimulated pineal
glands. From an earlier study by Govitrapong and Ebadi (1988) demonstrating
that glutamate inhibits NE-induced SNAT activity it appears that inhibition
of melatonin production by glutamate is most likely due to mechanisms
involving the SNAT enzyme. The present study extends the observations of
Govitrapong and Ebadi (1988) by demonstrating that inhibition of glutamate
occurs only if both ~-and a-adrenergic receptors are stimulated. If the~adrenergic receptor is stimulated alone, no inhibition occurs. This suggests
an important role for the a-adrenergic receptor in the glutamate induced
inhibition of melatonin synthesis.
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Because inhibitory effects of glutamate are rare, the possibility that cell
death contributed to the decrease in melatonin release was considered.
Glutamate-induced toxicity as seen in neurons is very complicated, involves
many steps and is not fully understood (Choi and Rothman 1990). When
cells are over stimulated by glutamate, i.e. too much is released or it is not
removed from the extracellular space, cells begin to swell as an excess amount
of sodium enters. This is followed by

c1- and water and leads to osmotic lysis

of the cells (Olney et al. 1986). Glutamate, via the NMDA receptor, can also
stimulate excess Ca2+ influx into cells. An increase in intracellular Ca2+
activates many enzymes including phospholipase A2 which leads to an
increase in arachidonic acid (Choi and Rothman 1990). Arachidonic acid can
lead to an increase in free radical formation via the enzymes lipoxygenase
and cyclooxygenase. Because activation of the a.-adrenergic receptor
stimulates arachidonic acid formation in the pineal gland, it might be
hypothesized that glutamate acting at its pineal binding site synergizes with
the a.-adrenergic receptor to produce toxic levels of this compound. Studies
designed to measure levels of arachidonic acid in glands treated with
glutamate and Iso and PE would test this hypothesis.
Another mechanism by which the Iso- and PE-induced production of
melatonin may be inhibited by glutamate may be through depolarization of
the pinealocyte membrane. It has been demonstrated that agents that cause
depolarization of the pinealocyte membrane, e.g. oubain and K+, lead to an
inhibition of the NE-induced membrane hyperpolarization as well as to an
inhibition of SNAT activity (Parfitt et al. 1975). Interestingly, a decrease in
cAMP formation was not noted in these experiments. In another study in
which the effects of a.MSH on pineal gland function were examined, it was
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noted that depolarization of the membrane by exMSH inhibits the ability of
NE to stimulate cAMP formation (Sakai et al. 1976). The mechanism by•
which membrane depolarization inhibits cAMP or SNAT activity is not
known.
In addition to the two possible aforementioned mechanisms of
glutamate inhibition of melatonin secretion, another possible mechanism
should be considered. While it has been well documented that activation of
the exl-adrenergic receptor can potentiate the P-adrenergic induced production
of cAMP (Klein et al. 1987), it has been recently been demonstrated that
exclusive activation of the ex isoform of PKC leads to the inhibition of cAMP
formation. The isoforms identified in the pineal gland are the ex (80%) and

p

(20%) forms. Glutamate may interact synergistically with the exl-adrenergic
receptor to stimulate production of the ex-form of the enzyme which would
then inhibit cAMP formation. This hypothesis could be tested by examing the
isoforms of PKC that are produced after treatment of the gland with
glutamate in conjunction with lso and PE.
The minimum concentration of glutamate required to inhibit
melatonin production was lmM, approximately 7 times the concentration of
glutamate found in plasma (Pratt 1976). When compared to doses known to
be toxic in neuronal cell culture, e.g. 100µM for 5 min (Choi and Rothman

1990), this dose appears excessively high. However, whole tissue such as that
used in these experiments possesses uptake systems for glutamate that
remove excess amino acid from the extracellular space. As demonstrated by
the significant increase in glutamate content of the pineal gland 2.5 hours
after administration of exogenous glutamate, the pineal gland is capable of
such uptake. Interestingly, the amount of glutamate taken up by the gland

92
did not produce overall levels of glutamate that were significantly higher
than those seen in non-perifused samples (18.08 + 0.94 and 15.58 + 2.86 µg/mg
protein, perifused and non-perifused tissue respectively). Other studies such
as those employing whole retina have also reported that high concentrations
of glutamate (0.3 - 30 mM) are required to evoke a physiological response
(Perlman et al. 1987; Zeevalk et al. 1989).
While the mechanism of glutamate's interaction with the Iso and PE
stimulated production of melatonin is not clear, it is probably not due to
binding of glutamate with any of the currently characterized glutamate
receptor subtypes. In agreement with the study in Chapter IV that
demonstrated an inability of kainate, NMDA and quisqualate (which has a
relatively high affinity for both the AMP A and metabotropic receptors) to
inhibit [3H]glutamate binding in the pineal gland, these agonists at 10-4M had
no effect on the Iso and PE stimulated production of melatonin. Likewise,
trans-ACPD, a ligand specific for the glutamate metabotropic receptor (Palmer
et al. 1989) and D,L-APB had no effect. A similar lack of stimulation by
glutamate agonists was seen in mammalian (kainic acid) and turtle
photoreceptors (Abrams et al. 1989; Tachibana and Kaneko 1988). Because
turtle retinal photoreceptors responded to L- and D-aspartate as well as Lglutamate, Tachibana and Keneko (1988) suggested that glutamate exerted its
effects on membrane depolarization via the interaction of glutamate with an
electrogenic uptake carrier. Other characteristics of the photoreceptor
response to glutamate included increased current fluctuations accompanying
the glutamate-induced current. Based on this observation, Tachibana and
Keneko (1988) suggested that an ion channel may be involved in the
glutamate induced response. Whether similar mechanisms are involved in
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glutamate's inhibition of melatonin production in the pineal gland is not
known.
The observation that glutamate must be administered before Iso and PE
in order to have an effect (see Figs. 6, 19) suggests an alternative mechanism
for glutamate's action, i.e. the conversion of glutamate to another compound.
Intracellular utilization of glutamate is supported by the observation that
glutamine content in the pineal increased by 27% after glutamate
administration. Similarly, it was reported that when [3H]glutamate was
incubated with brain tissue at 30°C for 60 minutes, up to 30% of the radiolabel
was not associated with glutamate at the end of the incubation period
(Anderson and Vickroy 1990). It is therefore conceivable that the inhibitory
effects of glutamate are mediated via its decarboxylation to GABA. While
GABA is found in only small amounts in the rat pineal (Mata et al. 1976), this
amino acid is able to inhibit melatonin production in vitro (Rosenstein et al.
1989). The stimulus for the release of GABA from the pineal is the activation

of the al adrenergic receptor (Rosenstein, et al. 1989). The conversion of
glutamate to GABA within the pineal gland would explain the inability of
glutamate to inhibit melatonin production when stimulated by Iso alone.
Activation of the cx-adrenergic receptor by PE would be required to release
GABA from the cells which would then allow it to bind to its membrane
receptor, although there is no direct evidence to support this hypothysis. This
explanation is not consistent with the observations of Govitrapong and Ebadi
(1988) who reported that L-allyl-glycine, a GAD inhibitor, did not inhibit the
glutamate induced inhibition of SNAT activity. These authors failed,
however, look at the affects of L-allyl-glycine alone on NE-stimulated SNAT
activity.
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The present observation that PE did not potentiate the !so-stimulated
secretion of melatonin was an unexpected finding. In the rat pineal gland, PE
has been demonstrated to potentiate the !so-stimulated production of second
messenger (cAMP) (Sugden et al. 1986; Vanecek et al. 1985) and SNAT activity
(Alphs and Lovenberg 1984; Klein et al. 1983; Sugden et al. 1984). While
potentiation of melatonin production by PE has been demonstrated in other
species such as hamster and ovine (Howell and Morgan 1991; Santana et al.
1989), it has not been demonstated unequivocally in rat. As reported in both
the hamster and ovine pineal gland, however, cAMP /SNAT activity and
melatonin production do not always parallel one another (Howell and
Morgan 1991; Nilsson and Reiter 1989). This suggests that an increase in
cAMP levels and SNAT activity may not necessarily be accompanied by an
increase in melatonin production. It is unlikely that the lack of potentiation
in the present study was due to a maximal effect on melatonin production
because the amount of hormone could be further increased with a higher
dose of Iso (IO-SM).
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CHAPTER VI
GENERAL DISCUSSION
These studies tested the hypothesis that glutamate modulates
melatonin production in the pineal gland of the rat. The role of the
adrenergic system in the production of the pineal gland hormone, melatonin,
is well known. NE, which is released from sympathetic nerve terminals at
night, binds to a- and ~-adrenergic receptors to stimulate the production of
pinealocyte cAMP. This increase in cAMP stimulates the transcription and
translation of the rate limiting enzyme in the synthesis of melatonin, SNAT.
Melatonin, which is synthesized from the amino acid tryptophan via
multienzymatic pathway, is released from the gland into the blood stream.
The proposal of a modulatory role for glutamate in this process in vivo
requires that several things be demonstrated including (see Fig. 1):

1) cell surface receptors for glutamate (Seel in Fig. 1)
2) an endogenous source of glutamate for these receptors (See _i in Fig. 2)
3) the ability of glutamate to influence melatonin production via binding to
these receptors (See 3A, ~ 3C, 3D in Fig. 1 and explanation below)
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1) Glutamate Binding Sites
In chapter IV, a postsynaptic binding site for glutamate in the rat pineal
gland is described. The pharmacological profile of this binding site suggests
that it does not fit into any of the known categories of glutamate receptor
described in brain. In further analyzing the nature of this glutamate binding
site, however, it becomes important to determine if a comparison with
neuronal glutamate receptors is appropriate. While the pineal gland is
considered a part of the brain (epithalamus) and is embryologically derived
from neuroectoderm, pinealocytes differ in many ways from neurons.
Referred to as paraneurons (Ueck and Wake 1977), pinealocytes, like neurons,
exhibit action potentials (Reuss 1987) and synthesize and release a known
neurotransmitter, (serotonin is released in response to a1-adrenergic
stimulation (Aloyo and Walker 1988). On the other hand, pinealocytes
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display many non-neuronal features. For example, there is no evidence for
intrapineal synapses like those seen between neurons. In addition, many
cytochemical neuronal markers such as neuronal adhesion molecule Ll,
synaptophysin and neurofilament marker R39 are not present in pinealocytes
(Schroder et al. 1990; Vollrath and Schroder 1987). Finally, a suggestion that
the receptors present on the gland may not be exactly like receptors present in
other parts of the brain comes from a study where it has been demonstrated
with the use of photoaffinity labeling that the J3-adrenergic receptor present in
the rat pineal has a lower molecular weight than the J3-adrenergic receptor
described in other tissue including brain (Dickinson et al. 1986).
Perhaps it would be more appropriate to compare pinealocytes with
retinal photoreceptors based on histochemical, morphological and
phylogenetic evidence. Accordingly, the glutamate binding site present in the
rat pineal may be more closely related to the glutamate binding site present
on photoreceptors. Recent characterization of glutamate receptors in turtle
photoreceptors using electrophysiological techniques indicates that these sites
are not similar to the glutamate binding sites within the rest of the brain
(Tachibana and Kaneko 1988). In the photoreceptor of the turtle, the
glutamate binding site has been characterized as a "functional" uptake site.
While none of the known glutamate agonists stimulated depolarization in
photoreceptors, D-aspartate and L-aspartate, substrates of the glutamate
uptake system were effective (Tachibana and Kaneko 1988). Addition of a
glutamate uptake inhibitor also reduced the glutamate-induced current.
Therefore, the possibility that the binding site described in this study is an
uptake site for glutamate must also be considered.
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There is no doubt that a glutamate uptake site is present in the pineal
gland as extracellular glutamate can be accumulated by this organ (chapter V,
Fig. 20). Whether this site is responsible for this uptake or whether there is
another, lower affinity uptake site, is unknown. While binding was
performed in Na 2 +, and c1- free conditions, it is possible that local tissue
concentrations of these ions remained high enough to stimulate glutamate
uptake. It would be important to examine the effects of a specific glutamate
uptake inhibitor such as L-trans-pyrrolidine-2,4-dicarboxylic acid on the ability
of glutamate to inhibit the Iso and PE-stimulated production of melatonin.
Based on the diversity of glutamate binding sites defined pharmacologically,
e.g. the NMDA, kainate, AMPA, APB, and metabotropic receptors in the CNS,
and the glutamate binding sites in photoreceptor and pituitary gland, as well
as those defined with the use of molecular techniques, the possibility that the
pineal gland of the rat possesses a unique type of glutamate receptor must also
be considered.
Assuming that glutamate exerts its effects on pinealocytes via binding
to either an uptake site or a receptor, the mechanism for glutamate inhibition
of Iso and PE-stimulated melatonin secretion remains an enigma. It was
originally hypothesized that glutamate inhibits the a- and ~-adrenergic
stimulated production of melatonin by inhibiting the a-adrenergic stimulated
production of inositol phosphates. It had been demonstrated in brain that
glutamate and quisqualate inhibited incorporation of [3H]inositol into the
larger phospholipid molecule. If glutamate or quisqualate were administered
before NE, it was demonstrated that activation of the a-adrenergic receptor
produced less IP3 (Jope and Li 1989). It had been assumed that the~adrenergic stimulated production of melatonin, like the ~-adrenergic
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stimulated production of cAMP and SNAT activity, would be potentiated by
activation of the a-adrenergic receptor. It was therefore hypothesized that
addition of glutamate to pineal glands stimulated with both a- and Padrenergic agonists would reduce melatonin secretion to the same extent that
activation of the a-adrenergic receptor would potentiate P-adrenergic
stimulated melatonin production. This idea was not borne out by our data
demonstrating lack of potentiation of melatonin production in glands treated
with both a and P-adrenergic agonist when compared to glands stimulated
with a P-adrenergic agonist alone (chapter V Fig. 4). In addition the role of
inositol phospholipid production in melatonin synthesis has been questioned
(Sugden et al. 1988; Sugden et al. 1987). Several other mechanisms for
glutamate inhibition of Iso- and PE-stimulated secretion of melatonin as
discussed in Chapter V include: A) cell death or toxicity; B) pinealocyte
depolarization; C) inhibition of cAMP by the a-isoform of PKC; and D)
conversion of glutamate to GABA (chapter VI Fig. 1).

2) Endogenous Glutamate
While glutamate can inhibit the secretion of melatonin in vitro, a
physiological role for this amino acid in vivo requires that a regular source of
glutamate be available to the gland. Our immunocytochemical data
demonstrated that glutamate is not concentrated in nerve terminals in the
pineal gland when compared to glutamate immunolabeling over other cell
types in the gland suggesting that the SCG is not a source of "transmitter"
glutamate. While glutamate may be tonically released and not stored for long
periods of time, there are, to my knowledge, no studies that have described a
co-localization or co-release of glutamate and NE. Central neuronal
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connections do not seem a likely source of glutamate as there is no
compelling evidence for the presence of such fibers in the pineal gland of the
rat. The possibility that glutamate is blood borne or found in the CSF may be
considered as the pineal gland has one of the highest flow rates of blood in
the body (on a per weight basis) (Goldman and Wurtrnan 1964) and is
surrounded by CSF. These possibilities, however, both seem unlikely because
blood and CSF do not have high levels of glutamate (0.15 mM and 0.4 µM
respectively) (Alfredsson et al. 1988; Pardridge 1979) and 0.5 mM glutamate
did not inhibit the Iso and PE stimulated production of melatonin in vitro
(Chapter V, Fig. 8). Another possibility is that the pineal gland itself serves as
a source of glutamate. It has been demonstrated in turtle photoreceptors that
glutamate is released upon depolarization of the cell (Copenhagen and Jahr
1989). NE, however, hyperpolarizes the pinealocyte membrane (Parfitt et al.
1975; Sakai and Marks 1972). The presence of glutamate binding sites in the
pineal gland without a definitive glutaminergic input is an obvious problem.
However, in many other brain regions mismatch between neurotransmitters
and their receptors have been documented (Herkenham and McLean 1986).

3) Glutamate Modulation of Melatonin Secretion

While glutamate administered before Iso and PE inhibits the amount
of melatonin released by the pineal gland in vitro, the physiological relevance
of this finding must be addressed in light of what has been called the duration
hypothysis. It has been suggested that what is physiologicaly important to the
animal is not an increase or decrease in the amount of melatonin that it is
exposed to, but the amount of time that the animal is exposed to it. For
example, the pineal gland of the aged Syrian hamster produces significantly
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less melatonin than the pineal gland of a younger animal (Reiter et al. 1980).
In spite of the overall decreased levels of melatonin, exposure of these
animals to short days will still induce gonadal regression. This indicates that
it is the duration of the melatonin signal that induces this change and not the
total amount of melatonin produced. Because the production of melatonin
in this study was followed for only 4 hours after stimulation by Iso and PE
(Chapter V, Fig. 6), it could not be discerned whether one hour of glutamate
pretreatment would shorten the overall duration of the melatonin signal.

It is interesting to note that the pineal gland has been suggested by
more than one author to serve as a model for events in the central nervous
system. In light of the observation made in this study, it is suggested that this
idea be approached with caution.
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